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Abstract 
 
The purpose of oral toxicity study A in the EU project G-TwYST was to assess the chronic and 
carcinogenic effects of genetically modified (GM) maize NK 603, grown both with and without the 
use of RoundUp, when fed to rats for a period of two years at incorporation rates of 11% and 33% in 
the feed. The effects were assessed relative to the responses for rats fed the near-isogenic non-GM 
maize, and the differences were compared, using a recently developed method for equivalence 
testing, to differences between non-GM feeds obtained in previous studies performed in the EU 
project GRACE.  
The results of G-TwYST study A, except for the histopathological results which are reported 
separately, are given in five reports: four specific reports about the statistical analysis for data 
measured after 3, 6, 12 and 24 months, and a main report summarising all study results (Goedhart & 
van der Voet 2018). This report is about the results after 6 months.  
No historical data for 6 months old rats were available. Therefore it was only possible to perform 
equivalence tests using the 3 months data from the GRACE study as reference data. Given tentative 
settings for regulatory parameters, for a set of 240 comparisons involving body weight, feed intake, 
haematology, differential white blood cell counts and clinical chemistry, equivalence was established 
in 92% of cases, close to the nominal confidence level of the test which was 95%. Equivalence was 
found to be more likely than lack of equivalence in all cases, except for Monocytes in females for 
feeding group NK33+. Note that this is a comparison between data obtained after 6 months for the 
current study, and data obtained after 3 months for the historical GRACE study.  
In addition to this primary analysis, this report also contains results for equivalence testing using 
external target effect sizes for a limited set of variables, results for classical statistical analysis of 
differences, graphs of standardised effect sizes such as performed in the GRACE study and results of 
a factorial analysis. 
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1 Introduction 
 
The purpose of oral toxicity study A in the EU project G-TwYST was to assess the effects of genetically 
modified (GM) maize NK 603, grown both with and without the use of RoundUp, when fed to rats for 
a period of one year (chronic toxicity study) and two years (carcinogenicity study), at incorporation 
rates of 11% and 33% in the feed. The effects of the GM maize were assessed relative to the 
responses for rats fed the near-isogenic non-GM maize. The chronic toxicity and carcinogenicity 
study ran in parallel. At 12 months part of the rats were euthanized and their organs were obtained, 
weighted and examined by the G-TwYST histopathological expert. The remaining rats were kept until 
24 months, or until premature death, and were then assessed in the same way.  
Rat weights and feed intake were measured weekly or bi-weekly. Haematology, clinical biochemistry 
in blood and urine, differential white blood cell counts, and urine volume and colour were obtained 
for a subset of animals after 3, 6, 12 and 24 months. This report describes in detail the results of the 
statistical analyses for the following data obtained after 6 months: 
• Body weight at 6 months, growth rate months 3-6, mean feed intake (35 cages/group); 
• Haematology (20 cages/group); 
• Differential white blood cell counts (20 cages/group); 
• Clinical biochemistry in blood (20 cages/group); 
• Clinical biochemistry in urine (10 cages/group); 
• Urine volume and colour (10 cages/group). 
This report is organised as follows. Section 2 describes the data obtained after 6 months, initial data 
pre-processing, graphical summaries of growth and feed intake over time, outlier identification and 
checking of assumptions which are made in the statistical analysis. Section 3 presents detailed results 
of the statistical analyses. More details are provided in several appendices to this report. For a 
description of the statistical methods, and for a summary and discussion of results for all months, the 
reader is referred to the main study A report (Goedhart & van der Voet 2018). 
2 Data 
2.1 Data obtained after 6 months in G-TwYST study A 
The available files for the data obtained after 6 months in G-TwYST study A are given in Table 1. 
GenStat programs “06-Males.gen” and “06-Females.gen” were used to combine all the data into 
single Excel files, separately for males and females. All animals survived the first 6 months, except for 
2 female rats and 1 male rat (Table 2). It is assumed that these premature deaths are not connected 
to the experiment.  
Some CHOL and cHGB were given as bounds; the number of such values are given in Table 3. The 
original Excel files with the haematology data (Tab_5 and Tab_6) contain remarks given in Table 4. 
Values with such remarks were set to missing, see for Table 6 for details. For most Urine variables 
only a limited number of values have been observed, see Table 5. A statistical analysis of uColour, 
uBil, uNit, uProtein, uGlu, uHemogl and uUrobili is not very useful. Therefore, only the Urine 
variables uVol, uVolW, uLeu, uOsmoll, uKeton and upH were statistically analysed. 
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Table 1 Data files for G-TwYST study A after 6 months. 
Data files after 6 months Date Time  Size (b) 
Tab_1_G_TwYST_2yr st_A_6_mon_Body weight_Mal.xlsx 09-01-2017 15:39  175,037 
Tab_2_G_TwYST_2yr st_A_6_mon_Body weight_Fem.xlsx 09-01-2017 15:40  175,585 
Correct data_rev_1_Feed consumption_12_mon_G_TwYST_A_Females.xlsx 20-10-2017 07:08  164,942 
Correkt data_rev_1_Feed consumption_12_mon_G_TwYST_A_Males.xlsx 20-09-2017 12:00  168,346 
Tab_5_G_TwYST_2yr st_A_6 month_Haemat_Mal.xlsx 03-01-2017 11:54  87,376 
Tab_6_G_TwYST_2yr st_A_6 month_Haemat_Fem.xlsx 03-01-2017 12:13  86,763 
Differential WBC G-TwYST A - after 6M final 12.12.17.xlsx 12-12-2017 13:17  37,026 
Tab_7a_G_TwYST_2yr st_A_6 mon_Clin_Chem_bl_Mal.xlsx 03-01-2017 12:18  100,265 
Tab_7b_G_TwYST_2yr st_A_6 mon_Clin_Chem_ur_Mal.xlsx 03-01-2017 12:21  84,688 
Tab_8a_G_TwYST_2yr st_A_6 mon_Clin_Chem_bl_Fem.xlsx 03-01-2017 12:22  99,943 
Tab_8b_G_TwYST_2yr st_A_6 mon_Clin_Chem_ur_Fem.xlsx 12-01-2017 07:45  84,746 
Bl_ur_6 month_G_TwYST_2yr st_A_Fem_time image.xlsx 11-01-2017 15:48  98,021 
Bl_ur_6 month_G_TwYST_2yr st_A_Mal_time image.xlsx 11-01-2017 15:14  98,290 
 
Table 2 Animals that died before the end of month 6. 
Sex Rat Cage Feed Day of Death 
Female 610 555 NK11- 86 
Female 785 643 Control 98 
Male 199 100 NK11+ 182 
 
Table 3 Number of animals for which bounded values were provided. 
Variable Males Females 
Con NK11- NK33- NK11+ NK33+ Con NK11- NK33- NK11+ NK33+ 
CHOL  < 1.16 - - - - - - 4 1 1 1 
cHGB  < 27.5 1 1 1 - 2 - - - - - 
cHGB  > 522.5 - 1 - - - - - 1 1 - 
ALP < 0.17 - - - - - - - 1 - - 
 
Table 4 Remarks by SZU in original Excel data files; the accompanying values have been set to 
missing. 
Variable Remark 
WBC High count WBC 
WBC High count of WBC and PLT, no calculated lymphocytes 
WBC Low WBC and platelet count, probably due to microclots 
HGB No calculated HGB (low blood) 
PLT Low platelet count, probably due to microclots 
PLT High count PLT 
PLT High count of WBC and PLT, no calculated lymphocytes 
PLT Low WBC and platelet count, probably due to microclots 
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Table 5 Urine variables with only a limited set of observed values which are given in the heading 
of each sub-tables The table entries give the number of times each value occurs for male 
and female rats. Only uLeu and uKeton were statistically analysed. 
uColour Missing 2 3   
Male 247 102 1   
Female 251 99 -   
uBil Missing 0    
Male 251 99    
Female 251 99    
uLeu Missing 0 25 100 500 
Male 251 15 56 26 2 
Female 251 54 37 8 - 
uNit Missing 0    
Male 252 98    
Female 251 99    
uProtein Missing 0.00 0.25 1.50  
Male 251 98 - 1  
Female 251 97 2 -  
uGlu Missing 1    
Male 251 99    
Female 251 99    
uHemogl Missing 0 10 25 250 
Male 251 91 4 3 1 
Female 251 94 2 1 2 
uKeton Missing 0.0 0.5 1.5 5.0 
Male 251 56 15 27 1 
Female 251 78 13 8 - 
uUrobili Missing 1    
Male 251 99    
Female 251 99    
 
2.2 Growth curves and feed intake 
For each individual rat a simple linear regression, 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊ℎ𝑡𝑡 = 𝛼𝛼 + 𝛽𝛽 𝑊𝑊𝑊𝑊𝑊𝑊𝑊𝑊, was fitted to the observed 
weights between weeks 13 and 27, and the growthRate was defined as 𝛾𝛾 = log(𝛽𝛽). In Appendix 1 
the observed weights are graphically displayed along with the fitted line and, in the bottom right 
corner, the resulting estimate of the growth rate 𝛾𝛾. Initially, absolute standardized residuals, 
resulting from the fitted curve, which were larger than 3, were marked and these were checked for 
errors by SZU. This led to some corrections. Some weights at week 13 were not equal to the same 
weights in the data file after 3 months, and these were also corrected. The corrections are listed in 
Table 6. The linear regression line generally fits very well. Only for the following animals one or more 
observed weights differ more than 5% from the fitted values: males 17, 18, 29, 149, 293 and females 
507, 509, 539, 546, 582, 594, 622, 639, 649, 663, 675, 722, 733, 787. However, again in general, 
these outlying weights do not seem to have a major impact on the estimated slope 𝛽𝛽 of the 
regression line. The final weight Weight_27 and the growthRate parameter 𝛾𝛾 were statistically 
analysed. The mean weight for each feeding group is given in Figure 1, while the mean weight gain 
per day per animal in each week is given in Figure 2. Feed consumption for each cage in units 
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g/animal/day is depicted in Appendix 2. The mean feed consumption for each feeding group is given 
in Figure 3.  
 
Figure 1 Mean body weights versus week for each feeding group for male rats (left) and for 
female rats (right). 
 
 
Figure 2 Mean body weights gain (g/day/animal) versus week for each feeding group for male 
rats (left) and for female rats (right). 
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Figure 3 Mean feed consumption (g/day/animal) versus week for each feeding group for male 
rats (left) and for female rats (right). 
2.3 Outliers and checking of ANOVA assumptions 
These analyses and changes to the data were made before the feeding group codes were unblinded. 
The cage means, after a log transformation, for each observed variable were statistically analysed by 
means of an analysis of variance using the model “Block + Group” according to the randomized block 
design. Grubbs’ outlier test at the 1% level was sequentially applied to the residuals to detect 
outliers. This resulted in a number of outliers which were first presented to the study director and 
then to the G-TwYST coordinator. Outliers were classified as either (1) typos or physiologically 
improbable values or (2) values that might be realistic. For the first category the values were set to 
missing, effectively removing the outlier completely. For the second category a statistical analysis 
without and with these outlier was performed. The analyses presented in this report are without the 
outliers. Analyses including outliers are presented in Appendix 11. Table 6 lists all the initially 
modified values and outliers. Residual plots which include the outliers (i.e. including the yellow 
values in Table 6) are given in Figure 4. From this it is clear that these are indeed outliers. 
Without these outliers cage means on the original scale are given in Appendix 3, while cage means 
after a log transformation of the individual data are given in Appendix 4. Normal probability plots of 
the ANOVA residuals, of an analysis on cage means after log transformation, are given in Appendix 5. 
To aid interpretation a 99% envelope is added to the probability plots, such that only values outside 
the envelop might be suspicious. Appendix 6 gives plots of residuals versus fitted values after the 
same analysis of variance. These residual plots are generally satisfactory implying that the ANOVA 
assumptions, homogeneity of variance and, less importantly, normality, are generally fulfilled. 
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Table 6 Values that have been modified, deleted, or were considered as possible outliers, before 
unblinding of the feeding groups. Values which are not coloured were modified or 
deleted following comments of SZU. The red and yellow values were presented to the 
G-TwYST coordinator. He decided which values should be deleted (red) and which values 
should be considered as possible outliers (yellow). Comments by the authors of this 
report are given in black, while comments of the G-TwYST coordinator are given in red. 
Sex Variable Animal Cage oldValue newValue Comment 
Males PLT 69 35 366 delete Comment in datafile: microclots 
Males PLT 83 42 484 delete Comment in datafile: microclots 
Males PLT 199 100 420 delete Comment in datafile: microclots 
Males PLT 227 114 425 delete Comment in datafile: microclots 
Males PLT 231 116 395 delete Comment in datafile: microclots 
Males PLT 320 160 153 delete Comment in datafile: microclots 
Males PLT 345 173 428 delete Comment in datafile: microclots 
Males PLT 349 175 510 delete Comment in datafile: microclots 
Males WBC 269 135 17.1 delete Comment in datafile: highCount 
Males Feed_27 199 100 28.35 delete Animal 199 died between week 25 
  
Males Weight_13 53 27 407.62 407.26 
Weight at beginning of this period 
must equal last weight in previous 
 
Males Weight_27 283 142 488.49 448.49 Weight at end of this period must equal first weight in next period 
Males Weight_23 175 88 467.75 508.62 Change of animals in common cage 
Males Weight_23 176 88 508.62 467.75 Change of animals in common cage 
Males Weight_23 256 128 482.30 428.30 Mistake in copying from primary 
 
Males MCV 281 141 58.8 outlier 
Coincidently two large values in the 
same cage; possible outlier 
Males MCV 282 141 59.6 outlier Coincidently two large values in the same cage; possible outlier 
Males ALT 199 100 2.4 outlier Not extremely large; possible outlier 
Males BIL 130 65 36.4 outlier Larger values in other months; possibly hemolysis; if so, delete 
Sex Variable Animal Cage oldValue newValue Comment 
Females PLT 516 508 361 delete Comment in datafile: microclots 
Females PLT 522 511 317 delete Comment in datafile: microclots 
Females PLT 579 540 290 delete Comment in datafile: microclots 
Females PLT 586 543 304 delete Comment in datafile: microclots 
Females PLT 588 544 1853 delete Comment in datafile: highCount 
Females PLT 592 546 315 delete Comment in datafile: microclots 
Females PLT 680 590 1868 delete Comment in datafile: highCount 
Females PLT 846 673 98 delete Comment in datafile: microclots 
Females WBC 680 590 24 delete Comment in datafile: highCount 
Females Feed_15 785 643 21.95 delete Animal 785 died between week 13 
  Females Weight_13 791 646 239.28 239.38 Weight at beginning of this period 
      
 
Females Weight_13 803 652 261.39 261.99 Weight at beginning of this period 
      
 
Females Lymphocytes 616 558 24 outlier Extremely small value 
Females Neutrophils 616 558 69.5 outlier Extremely large value 
Females MCV 718 609 66 outlier 
Animal has consistent large values 
in months 3, 6, 12; possible outlier 
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Females BIL 649 575 47.7 outlier 
Two large values for BIL (K also 
large); possibly hemolysis; if so, 
delete; 
      
Females BIL 746 623 45.7 outlier 
Two large values for BIL; possibly 
hemolysis; if so, delete 
Females K 649 575 8.4 delete There is a larger value (BIL also large); definitely hemolysis; delete 
Females Na 769 635 157 delete Not extremely large; too high; 
  
 
 
Figure 4 Residuals along the y-axis versus fitted values 
along the x-axis resulting from an analysis of variance on 
cage means after log transforming the data. Solid 
symbols denote outliers found by sequentially applying 
Grubbs’ outlier test at the 1% level to the residuals. 
 
 
2.4 Summary tables  
Summary tables, on the original non-transformed scale, of number of observations, means, standard 
deviations and coefficients of variation (%), classified by the feeding groups, are given in Table 7 for 
males and in Table 8 for females. These tables were obtained by first calculating cage means and 
then calculating the summary statistics. The number of cages per feeding group is 35 for weights, 20 
for haematology, differential WBC and clinical biochemistry, and 10 for urine data. 
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Table 7 Summary statistics for male rats classified by the feeding groups: number of cages (N), means (Mean), standard deviations (Sd) and 
coefficients of variation (CV). The summary statistics are obtained from cage means. 
Weights Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Weight_27 35 500 30.0 6.0 35 493 37.4 7.6 35 497 39.7 8.0 35 496 36.8 7.4 35 503 37.0 7.4 
growthRate 35 1.60 0.15 9.7 35 1.59 0.17 10.8 35 1.60 0.18 11.4 35 1.57 0.18 11.3 35 1.63 0.21 12.7 
FeedMean 35 19.9 0.73 3.7 35 19.6 1.27 6.5 35 19.5 1.27 6.5 35 19.7 1.16 5.9 35 20.3 1.32 6.5 
Haematology Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
WBC 20 9.1 1.63 17.8 20 8.9 1.95 21.9 20 10.8 1.88 17.4 20 10.5 1.84 17.6 20 9.6 1.94 20.1 
RBC 20 8.46 0.33 4.0 20 8.49 0.31 3.7 20 8.47 0.28 3.3 20 8.45 0.28 3.3 20 8.52 0.26 3.0 
HGB 20 15.6 0.51 3.3 20 15.7 0.57 3.6 20 15.8 0.53 3.3 20 15.6 0.48 3.1 20 15.9 0.43 2.7 
HCT 20 45.8 1.54 3.4 20 46.0 1.45 3.1 20 46.2 1.67 3.6 20 45.6 1.47 3.2 20 46.4 1.25 2.7 
MCV 19 54.0 0.78 1.4 20 54.3 1.47 2.7 20 54.6 1.48 2.7 20 54.0 1.15 2.1 20 54.5 0.98 1.8 
MCH 20 18.5 0.61 3.3 20 18.6 0.82 4.4 20 18.7 0.64 3.4 20 18.5 0.55 2.9 20 18.7 0.52 2.8 
MCHC 20 34.1 0.62 1.8 20 34.2 0.79 2.3 20 34.3 0.61 1.8 20 34.3 0.71 2.1 20 34.3 0.56 1.6 
PLT 20 829 44 5.3 20 812 105 13.0 20 872 88 10.1 20 864 67 7.7 20 865 112 12.9 
LYMR 20 71.4 4.48 6.3 20 69.9 4.90 7.0 20 70.5 6.07 8.6 20 71.5 6.06 8.5 20 72.3 3.99 5.5 
LYMA 20 6.52 1.17 17.9 20 6.19 1.34 21.6 20 7.53 1.33 17.7 20 7.47 1.37 18.4 20 6.99 1.67 23.9 
diffWBC Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Lymphocytes 20 69.7 5.24 7.5 20 70.8 4.56 6.4 20 68.7 5.32 7.7 20 70.0 6.50 9.3 20 71.3 4.33 6.1 
Neutrophils 20 27.0 4.86 18.0 20 26.1 4.02 15.4 20 27.4 5.30 19.3 20 26.3 5.79 22.0 20 25.1 3.99 15.9 
Monocytes 20 1.20 0.49 40.9 20 0.90 0.39 43.7 20 1.10 0.52 46.9 20 0.99 0.50 50.3 20 1.02 0.36 35.3 
Eosinophils 20 2.20 1.20 54.5 20 2.16 1.31 60.4 20 2.75 1.25 45.3 20 2.64 1.65 62.6 20 2.53 0.85 33.5 
ClinChem Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
ALP 20 1.39 0.30 21.7 20 1.44 0.36 24.8 20 1.34 0.30 22.8 20 1.35 0.24 17.6 20 1.37 0.34 24.5 
ALT 20 0.68 0.09 12.7 20 0.70 0.16 23.4 20 0.70 0.15 21.8 20 0.68 0.12 17.8 20 0.69 0.10 14.5 
AST 20 2.09 0.41 19.7 20 2.15 0.42 19.4 20 2.25 0.42 18.6 20 2.15 0.32 15.0 20 2.11 0.31 14.8 
BIL 20 7.33 1.28 17.5 20 7.54 1.49 19.8 20 8.34 2.15 25.8 20 7.99 1.61 20.2 20 7.83 1.29 16.4 
ALB 20 35.0 1.24 3.5 20 35.0 1.32 3.8 20 35.3 1.35 3.8 20 35.2 1.32 3.8 20 35.2 1.35 3.8 
TP 20 64.6 1.99 3.1 20 64.3 1.59 2.5 20 64.4 1.72 2.7 20 65.0 1.53 2.3 20 64.4 1.78 2.8 
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Glu 20 5.94 0.81 13.7 20 5.79 0.78 13.5 20 5.87 0.75 12.7 20 6.04 0.78 12.8 20 6.19 0.57 9.2 
CHOL 20 2.20 0.27 12.2 20 2.26 0.23 10.1 20 2.23 0.28 12.7 20 2.21 0.27 12.4 20 2.29 0.30 13.3 
TAG 20 1.24 0.50 40.0 20 1.29 0.48 37.4 20 1.33 0.47 35.4 20 1.39 0.53 38.1 20 1.30 0.43 33.5 
Crea 20 42.3 3.67 8.7 20 41.0 3.78 9.2 20 41.8 3.95 9.5 20 42.4 3.52 8.3 20 40.8 3.73 9.2 
Urea 20 5.16 0.61 11.8 20 5.02 0.75 14.9 20 5.16 0.59 11.5 20 5.19 0.60 11.5 20 5.10 0.51 10.0 
cHGB 20 63.6 23.1 36.3 20 82.4 59.3 72.0 20 84.3 49.0 58.1 20 82.6 40.6 49.2 20 72.2 31.5 43.6 
Ca 20 2.52 0.044 1.7 20 2.52 0.048 1.9 20 2.54 0.056 2.2 20 2.54 0.056 2.2 20 2.52 0.048 1.9 
Cl 20 102 1.36 1.3 20 102 1.38 1.4 20 101 1.44 1.4 20 101 1.25 1.2 20 102 1.18 1.2 
K 20 5.06 0.32 6.3 20 5.17 0.59 11.5 20 5.25 0.46 8.7 20 5.32 0.48 9.0 20 5.13 0.37 7.1 
Na 20 144 1.80 1.3 20 144 2.23 1.6 20 144 1.78 1.2 20 144 1.69 1.2 20 143 1.39 1.0 
P 20 2.04 0.26 12.6 20 1.99 0.27 13.5 20 2.05 0.20 9.6 20 2.09 0.21 10.1 20 2.02 0.18 9.0 
Urine Control NK11- NK33- NK11+ NK33+ 
Male N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
uVol 10 20.5 3.82 18.6 10 21.4 2.85 13.3 10 16.8 5.26 31.4 10 19.0 5.71 30.1 10 21.4 4.65 21.8 
uVolW 10 4.16 0.84 20.2 10 4.38 0.61 14.0 10 3.38 0.91 27.0 10 3.95 1.37 34.8 10 4.30 0.89 20.7 
uLeu 10 42.5 29.6 69.6 10 32.5 22.2 68.3 10 80.0 81.7 102.1 10 57.5 76.9 133.7 10 38.8 23.2 59.8 
uOsmoll 10 420 85 20.1 10 379 58 15.2 10 521 129 24.7 10 466 135 29.0 10 405 84 20.9 
uKeton 10 0.72 0.95 131.5 10 0.48 0.48 100.6 10 0.72 0.53 73.5 10 0.47 0.55 114.9 10 0.33 0.47 145.3 
upH 10 6.82 0.33 4.9 10 6.72 0.22 3.3 10 6.73 0.18 2.7 10 6.85 0.21 3.1 10 6.67 0.35 5.3 
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Table 8 Summary statistics for female rats classified by the feeding groups: number of cages (N), means (Mean), standard deviations (Sd) and 
coefficients of variation (CV). The summary statistics are obtained from cage means. 
Weights Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Weight_27 35 272 19.0 7.0 35 270 18.9 7.0 35 270 17.4 6.4 35 269 20.7 7.7 35 271 19.4 7.2 
growthRate 35 0.59 0.25 42.0 35 0.62 0.31 50.5 35 0.55 0.34 61.3 35 0.55 0.32 58.2 35 0.61 0.31 50.8 
FeedMean 35 14.2 0.86 6.1 35 14.3 1.19 8.3 35 14.4 1.04 7.3 35 14.3 1.13 7.9 35 14.6 1.18 8.0 
Haematology Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
WBC 20 5.86 1.35 23.1 20 5.97 0.94 15.8 20 6.12 1.71 27.9 20 5.59 1.27 22.6 20 6.05 1.30 21.5 
RBC 20 7.66 0.30 3.9 20 7.64 0.25 3.2 20 7.71 0.30 3.9 20 7.68 0.19 2.5 20 7.72 0.27 3.6 
HGB 20 15.6 0.44 2.8 20 15.4 0.52 3.4 20 15.5 0.29 1.9 20 15.4 0.29 1.9 20 15.5 0.41 2.6 
HCT 20 44.1 1.55 3.5 20 44.0 1.45 3.3 20 44.3 1.03 2.3 20 44.1 0.88 2.0 20 44.2 1.41 3.2 
MCV 20 57.7 0.96 1.7 20 57.6 0.90 1.6 20 57.4 1.14 2.0 20 57.4 0.80 1.4 20 57.2 0.99 1.7 
MCH 20 20.4 0.52 2.5 20 20.2 0.53 2.6 20 20.1 0.69 3.4 20 20.1 0.49 2.5 20 20.1 0.64 3.2 
MCHC 20 35.3 0.76 2.1 20 35.1 0.76 2.2 20 34.9 0.40 1.2 20 34.9 0.59 1.7 20 35.2 0.87 2.5 
PLT 20 843 82 9.7 20 794 63 7.9 20 812 69 8.4 20 786 92 11.7 20 819 117 14.3 
LYMR 20 72.4 3.94 5.4 20 71.2 4.03 5.7 20 71.6 5.22 7.3 20 72.2 3.88 5.4 20 71.1 5.25 7.4 
LYMA 20 4.21 0.85 20.3 20 4.26 0.75 17.6 20 4.35 1.21 27.8 20 4.03 0.94 23.4 20 4.28 1.04 24.2 
diffWBC Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
Lymphocytes 20 67.7 4.28 6.3 20 67.5 4.34 6.4 20 67.4 3.91 5.8 20 67.5 3.49 5.2 20 69.3 4.54 6.5 
Neutrophils 20 29.0 4.25 14.7 20 29.5 4.07 13.8 20 29.6 4.13 14.0 20 29.3 3.79 12.9 20 27.9 4.33 15.5 
Monocytes 20 1.13 0.60 53.7 20 0.85 0.64 75.4 20 1.01 0.61 60.7 20 0.94 0.36 38.6 20 0.66 0.39 59.1 
Eosinophils 20 2.24 0.76 33.9 20 2.21 0.86 38.7 20 1.97 0.98 49.6 20 2.34 0.77 33.0 20 2.12 1.23 58.0 
ClinChem Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
ALP 20 0.65 0.13 19.8 20 0.61 0.14 22.7 20 0.63 0.16 26.3 20 0.62 0.13 20.9 20 0.61 0.16 25.4 
ALT 20 0.62 0.14 22.4 20 0.61 0.13 20.4 20 0.64 0.12 18.6 20 0.55 0.10 18.1 20 0.61 0.09 15.1 
AST 20 1.95 0.36 18.3 20 1.84 0.34 18.5 20 2.11 0.56 26.8 20 1.81 0.30 16.4 20 2.09 0.40 19.1 
BIL 20 8.37 1.21 14.4 20 8.34 0.78 9.3 20 8.75 2.02 23.0 20 8.24 1.50 18.2 20 8.36 1.32 15.7 
ALB 20 41.5 1.93 4.6 20 41.8 2.27 5.4 20 42.0 2.93 7.0 20 42.4 2.56 6.0 20 41.3 2.70 6.5 
TP 20 69.6 2.59 3.7 20 69.7 2.73 3.9 20 70.2 3.54 5.0 20 70.2 2.75 3.9 20 69.1 2.37 3.4 
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Glu 20 5.55 0.67 12.1 20 5.37 0.76 14.1 20 5.26 0.61 11.5 20 5.45 0.74 13.6 20 5.48 0.74 13.6 
CHOL 20 2.23 0.42 19.0 20 2.16 0.41 18.9 20 2.06 0.42 20.2 20 2.01 0.32 15.7 20 2.10 0.35 16.6 
TAG 20 0.82 0.24 29.1 20 0.85 0.40 47.6 20 0.74 0.17 23.4 20 0.74 0.20 27.5 20 0.78 0.19 24.0 
Crea 20 43.3 7.27 16.8 20 42.5 4.87 11.4 20 41.5 3.88 9.3 20 43.7 6.78 15.5 20 43.5 3.48 8.0 
Urea 20 5.52 0.55 10.0 20 5.76 0.54 9.3 20 5.64 0.55 9.8 20 5.50 0.42 7.6 20 5.68 0.49 8.6 
cHGB 20 75.2 22.2 29.5 20 77.0 15.9 20.7 20 92.5 56.5 61.1 20 84.8 53.2 62.7 20 71.8 17.6 24.5 
Ca 20 2.53 0.045 1.8 20 2.54 0.072 2.8 20 2.56 0.072 2.8 20 2.55 0.067 2.6 20 2.53 0.051 2.0 
Cl 20 101 1.58 1.6 20 102 1.45 1.4 20 102 1.67 1.6 20 102 1.48 1.5 20 101 1.85 1.8 
K 20 4.17 0.32 7.7 20 4.22 0.29 6.8 20 4.56 0.57 12.6 20 4.32 0.31 7.2 20 4.19 0.35 8.3 
Na 20 142 2.28 1.6 20 142 2.04 1.4 20 142 1.97 1.4 20 142 2.06 1.4 20 143 2.19 1.5 
P 20 1.34 0.21 16.0 20 1.33 0.23 17.1 20 1.41 0.26 18.2 20 1.35 0.26 19.0 20 1.29 0.16 12.0 
Urine Control NK11- NK33- NK11+ NK33+ 
Female N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV N Mean Sd CV 
uVol 10 16.8 3.95 23.6 10 16.8 6.01 35.7 10 20.4 5.61 27.4 10 17.8 6.26 35.3 10 13.0 2.97 22.9 
uVolW 10 6.34 1.58 25.0 10 6.23 1.99 31.9 10 7.68 2.31 30.0 10 6.59 2.27 34.4 10 4.92 1.11 22.6 
uLeu 10 16.2 16.7 102.9 10 26.2 34.1 129.8 10 15.0 19.4 129.1 10 12.5 15.6 124.7 10 16.2 14.5 89.2 
uOsmoll 10 381 99 25.9 10 409 131 32.1 10 327 83 25.5 10 404 193 47.7 10 448 108 24.0 
uKeton 10 0.20 0.37 184.5 10 0.25 0.46 182.6 10 0.22 0.30 133.0 10 0.12 0.24 194.4 10 0.12 0.24 194.4 
upH 10 6.38 0.18 2.8 10 6.25 0.26 4.2 10 6.52 0.22 3.4 10 6.33 0.37 5.9 10 6.30 0.16 2.5 
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3 Statistical analysis 
 
The statistical methods are described in the main study A report (Goedhart & van der Voet 2018). 
3.1 Equivalence testing using historical data 
The sample size in the current study, i.e. the number of cages per feeding group, equals 35 for the 
weight variables and 20 for haematology, differential white blood cell counts, and for clinical 
biochemistry. These sample sizes were used as the regulatory replication 𝑛𝑛0 in the equivalence 
analysis. Moreover regulatory values 𝛼𝛼 = 0.05 and 𝛽𝛽 = 0.05 were employed. Equivalence testing 
was only performed for those variables that were also observed in the GRACE study. Note that this is 
a comparison between data obtained after 6 months for the current study, and data obtained after 3 
months for the historical GRACE study.  
Each GMO feed was tested for equivalence with respect to the control feed. The DWE intervals 
showing the main results of the equivalence tests for 30 variables are given in Figure 5 to Figure 8. 
The hypothesis of no difference is rejected in case the interval does not contain zero, which is 
denoted by fuchsia coloured estimates. The non-equivalence hypothesis is rejected when the interval 
fully lies inside the interval (-1,1). For further interpretation the 95% confidence intervals for the 
ratios are given in Table 9 and Table 10. These confidence intervals at the ratio scale are also given in 
Figure 9 to Figure 16, with inclusion of the estimated equivalence limits (red bars) and their 
uncertainty (blue bars). Note that the latter graphs cannot be used directly for performing the 
equivalence test. However, they show the effects and equivalence limits at a more familiar scale. 
The DWE equivalence test depends, among other things, on the ratio of the residual variance of the 
current study and the residual variance of the historical studies. In case this variance ratio (VR) is 
small the corresponding DWE interval will generally be short, and when VR is large the interval will 
large. The ratio of the residual variances is given in Figure 17. Large ratios are observed in males for 
MCV, MCH, MCHC and Lymphocytes, and in females for MCHC, Monocytes and CHOL.  
Among 8×30 = 240 equivalence tests, there were 20 failures (8.3%) to prove equivalence (i.e. reject 
the hypothesis of non-equivalence), which is close to the 5% level of the test. For all these failures 
the ratio of the residual variances is large (Figure 17). For only 1 of these 20 cases (Monocytes, 
females NK33+) the median estimate was outside the equivalence limits, therefore for the other 19 
cases equivalence is still more likely than lack of equivalence according to the terminology of EFSA 
(2011a). The 20 cases were observed in males for MCV (2x), MCH (4x) and Lymphocytes (4x), and in 
females for MCHC (2x), Monocytes (4x) and CHOL (4x).  
Although not the primary result of the equivalence analysis, it can also be observed from the fuchsia 
symbols in Figure 5 to Figure 8 and from Table 9 and Table 10 that, for those variables for which the 
equivalence test is performed, the number of significant differences, employing classical two-sided 
t-tests at the 5% level, equals 12 (5% of 240 difference tests, 8 for males and 4 for females), which is 
again close to the 5% level of the test. Only in one of these cases (Monocytes, females NK33+) there 
was both a significant difference and a failure to show equivalence.  
For all difference tests, i.e. including those for which the equivalence test was not performed, 14 out 
of 320 t-tests were significant which is 4.4% of the tests (Table 9 and Table 10).   
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Figure 5 Equivalence testing of NK11- and NK33- versus the control feed for males. For estimates 
(square symbols) on the left of zero the GM feed has a smaller mean than the control 
feed. See Table 9, Figure 9 and Figure 10 for further interpretation. Endpoints labelled 
with a golden background have a large residual variance compared to the historical 
studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Figure 6 Equivalence testing of NK11+ and NK33+ versus the control feed for males. For estimates 
(square symbols) on the left of zero the GM feed has a smaller mean than the control 
feed. See Table 9, Figure 11 and Figure 12 for further interpretation. Endpoints labelled 
with a golden background have a large residual variance compared to the historical 
studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Figure 7 Equivalence testing of NK11- and NK33- versus the control feed for females. For 
estimates (square symbols) on the left of zero the GM feed has a smaller mean than the 
control feed. See Table 10, Figure 13 and Figure 14 for further interpretation. Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Figure 8 Equivalence testing of NK11+ and NK33+ versus the control feed for females. For 
estimates (square symbols) on the left of zero the GM feed has a smaller mean than the 
control feed. See Table 10, Figure 15 and Figure 16 for further interpretation. Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). Fuchsia coloured symbols denote a significant difference. 
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Table 9 95% Confidence interval plus estimate for the ratio Δ of the GMO feeds versus the Control feed for males. Intervals are based on an ANOVA 
with 5 feeding groups. Ratios with corresponding Intervals that do not encompass the value 1 are coloured red; this is equivalent to a 
significant difference according to a t-test with significance level 5%. 
Weights NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Weight_27 0.961 0.985 1.009 0.967 0.991 1.016 0.965 0.989 1.014 0.979 1.004 1.029 
growthRate 0.923 0.991 1.065 0.931 1.001 1.075 0.902 0.969 1.041 0.956 1.027 1.103 
FeedMean 0.958 0.980 1.003 0.955 0.978 1.001 0.963 0.986 1.009 0.993 1.016 1.040 
Haematology NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
WBC 0.851 0.953 1.067 1.055 1.181 1.322 1.024 1.146 1.283 0.936 1.048 1.173 
RBC 0.981 1.003 1.026 0.979 1.001 1.024 0.977 0.999 1.022 0.986 1.008 1.031 
HGB 0.985 1.004 1.024 0.992 1.012 1.032 0.980 0.999 1.019 0.998 1.018 1.038 
HCT 0.985 1.004 1.024 0.988 1.008 1.028 0.976 0.996 1.015 0.993 1.012 1.032 
MCV 0.992 1.006 1.021 0.998 1.013 1.027 0.988 1.002 1.017 0.996 1.010 1.025 
MCH 0.979 1.001 1.024 0.989 1.011 1.034 0.978 1.000 1.023 0.987 1.010 1.033 
MCHC 0.988 1.000 1.013 0.992 1.004 1.017 0.992 1.004 1.016 0.993 1.005 1.018 
PLT 0.909 0.970 1.036 0.978 1.044 1.115 0.970 1.036 1.106 0.962 1.027 1.097 
LYMR 0.936 0.976 1.019 0.945 0.986 1.029 0.958 0.999 1.043 0.971 1.013 1.057 
LYMA 0.825 0.931 1.051 1.027 1.159 1.308 1.015 1.145 1.293 0.942 1.063 1.200 
diffWBC NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Lymphocytes 0.977 1.018 1.060 0.947 0.987 1.028 0.964 1.005 1.047 0.984 1.025 1.068 
Neutrophils 0.882 0.973 1.075 0.922 1.018 1.124 0.881 0.973 1.074 0.847 0.935 1.032 
Monocytes 0.598 0.752 0.947 0.710 0.894 1.125 0.617 0.777 0.978 0.692 0.871 1.096 
Eosinophils 0.698 0.980 1.377 0.908 1.275 1.791 0.772 1.085 1.524 0.886 1.244 1.748 
ClinChem NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
ALP 0.929 1.020 1.119 0.874 0.959 1.053 0.889 0.976 1.072 0.898 0.986 1.082 
ALT 0.934 1.006 1.084 0.944 1.017 1.096 0.911 0.982 1.058 0.937 1.010 1.088 
AST 0.935 1.028 1.129 0.974 1.070 1.176 0.937 1.030 1.131 0.921 1.012 1.112 
BIL 0.933 1.025 1.127 1.017 1.117 1.228 0.984 1.081 1.188 0.970 1.066 1.171 
ALB 0.977 0.998 1.020 0.985 1.006 1.028 0.984 1.005 1.026 0.983 1.004 1.026 
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TP 0.980 0.995 1.012 0.981 0.997 1.013 0.990 1.006 1.023 0.981 0.997 1.013 
Glu 0.908 0.973 1.043 0.919 0.985 1.055 0.946 1.014 1.087 0.973 1.043 1.117 
CHOL 0.964 1.032 1.106 0.946 1.013 1.085 0.933 0.999 1.071 0.967 1.036 1.110 
TAG 0.943 1.047 1.161 0.981 1.088 1.207 1.007 1.118 1.240 0.954 1.059 1.175 
Crea 0.924 0.968 1.015 0.941 0.987 1.034 0.955 1.001 1.049 0.919 0.964 1.010 
Urea 0.913 0.968 1.026 0.942 0.999 1.059 0.947 1.004 1.065 0.930 0.987 1.046 
cHGB 0.931 1.162 1.451 0.997 1.244 1.553 0.996 1.243 1.552 0.880 1.099 1.371 
Ca 0.988 0.999 1.010 0.994 1.005 1.017 0.993 1.005 1.016 0.988 0.999 1.010 
Cl 0.993 1.000 1.007 0.989 0.996 1.003 0.992 0.998 1.005 0.992 0.999 1.006 
K 0.969 1.016 1.065 0.985 1.032 1.082 1.001 1.049 1.100 0.966 1.013 1.062 
Na 0.997 1.002 1.008 0.995 1.001 1.006 0.996 1.001 1.007 0.991 0.997 1.002 
P 0.914 0.972 1.033 0.948 1.008 1.071 0.963 1.024 1.089 0.930 0.989 1.052 
Urine NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Males Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
uVol 0.870 1.070 1.315 0.654 0.804 0.989 0.737 0.907 1.115 0.843 1.036 1.274 
uVolW 0.871 1.081 1.342 0.652 0.809 1.004 0.741 0.920 1.142 0.830 1.031 1.280 
uLeu 0.551 0.896 1.458 0.922 1.500 2.441 0.663 1.079 1.755 0.582 0.947 1.540 
uOsmoll 0.750 0.918 1.124 0.992 1.215 1.488 0.895 1.096 1.342 0.787 0.964 1.180 
uKeton 0.497 0.919 1.700 0.657 1.215 2.247 0.497 0.919 1.700 0.409 0.756 1.399 
upH 0.718 0.905 1.141 0.718 0.905 1.141 0.813 1.025 1.293 0.683 0.861 1.085 
 
  
G-TwYST Study A  Statistical report month 6 
21 
 
Table 10 95% Confidence interval plus estimate for the ratio Δ of the GMO feeds versus the Control feed for females. Intervals are based on an ANOVA 
with 5 feeding groups. Ratios with corresponding Intervals that do not encompass the value 1 are coloured red; this is equivalent to a 
significant difference according to a t-test with significance level 5%. 
Weights NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Weight_27 0.972 0.994 1.017 0.970 0.992 1.014 0.969 0.991 1.013 0.973 0.995 1.018 
growthRate 0.923 0.991 1.065 0.931 1.001 1.075 0.902 0.969 1.041 0.956 1.027 1.103 
FeedMean 0.974 1.004 1.035 0.979 1.009 1.040 0.975 1.005 1.036 0.998 1.029 1.060 
Haematology NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
WBC 0.912 1.036 1.178 0.904 1.026 1.164 0.846 0.960 1.089 0.910 1.032 1.171 
RBC 0.976 0.998 1.021 0.984 1.006 1.029 0.981 1.003 1.026 0.987 1.009 1.032 
HGB 0.976 0.991 1.008 0.978 0.994 1.009 0.973 0.988 1.004 0.981 0.997 1.013 
HCT 0.979 0.998 1.017 0.986 1.004 1.023 0.980 0.998 1.017 0.982 1.000 1.019 
MCV 0.989 0.999 1.010 0.984 0.995 1.005 0.985 0.995 1.006 0.981 0.991 1.002 
MCH 0.975 0.993 1.011 0.969 0.987 1.005 0.967 0.985 1.003 0.970 0.988 1.006 
MCHC 0.981 0.994 1.006 0.977 0.989 1.002 0.977 0.990 1.002 0.985 0.997 1.009 
PLT 0.884 0.944 1.007 0.908 0.968 1.032 0.877 0.935 0.997 0.912 0.972 1.036 
LYMR 0.945 0.982 1.021 0.952 0.989 1.027 0.962 0.999 1.037 0.944 0.981 1.019 
LYMA 0.898 1.032 1.186 0.886 1.016 1.165 0.836 0.959 1.100 0.881 1.011 1.159 
diffWBC NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
Lymphocytes 0.968 1.001 1.036 0.964 0.997 1.031 0.965 0.998 1.032 0.991 1.025 1.060 
Neutrophils 0.933 1.014 1.102 0.947 1.027 1.115 0.936 1.016 1.102 0.890 0.966 1.048 
Monocytes 0.561 0.764 1.039 0.653 0.885 1.198 0.691 0.936 1.268 0.498 0.674 0.913 
Eosinophils 0.726 0.982 1.329 0.629 0.847 1.141 0.795 1.071 1.442 0.642 0.864 1.164 
ClinChem NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
ALP 0.831 0.927 1.035 0.828 0.922 1.027 0.845 0.941 1.048 0.838 0.933 1.040 
ALT 0.892 0.989 1.097 0.926 1.026 1.136 0.795 0.880 0.975 0.895 0.992 1.098 
AST 0.847 0.956 1.079 0.943 1.062 1.196 0.820 0.923 1.039 0.941 1.060 1.194 
BIL 0.940 1.014 1.095 0.957 1.032 1.112 0.910 0.981 1.058 0.928 1.000 1.078 
ALB 0.974 1.006 1.039 0.979 1.011 1.043 0.988 1.020 1.053 0.962 0.993 1.025 
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TP 0.977 1.000 1.023 0.985 1.007 1.030 0.986 1.008 1.031 0.971 0.993 1.016 
Glu 0.897 0.960 1.028 0.886 0.947 1.013 0.915 0.978 1.046 0.920 0.984 1.052 
CHOL 0.875 0.978 1.094 0.824 0.919 1.026 0.811 0.905 1.010 0.845 0.943 1.053 
TAG 0.862 0.985 1.127 0.802 0.915 1.044 0.800 0.913 1.041 0.848 0.968 1.104 
Crea 0.935 0.992 1.052 0.914 0.968 1.026 0.954 1.011 1.071 0.960 1.017 1.077 
Urea 0.988 1.045 1.105 0.962 1.016 1.074 0.944 0.997 1.054 0.974 1.029 1.087 
cHGB 0.905 1.055 1.229 0.947 1.101 1.280 0.875 1.018 1.183 0.838 0.974 1.133 
Ca 0.988 1.002 1.015 0.996 1.009 1.023 0.993 1.006 1.020 0.984 0.997 1.010 
Cl 0.998 1.006 1.014 1.000 1.008 1.016 0.999 1.007 1.015 0.992 1.000 1.008 
K 0.969 1.017 1.067 1.033 1.082 1.135 0.987 1.035 1.085 0.959 1.005 1.053 
Na 0.995 1.001 1.007 0.993 0.999 1.005 0.994 1.000 1.006 0.995 1.001 1.007 
P 0.923 1.010 1.105 0.951 1.039 1.136 0.916 1.001 1.093 0.881 0.962 1.052 
Urine NK11- vs Control NK33- vs Control NK11+ vs Control NK33+ vs Control 
Females Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper Lower Ratio Upper 
uVol 0.664 0.885 1.182 0.886 1.171 1.547 0.769 1.017 1.344 0.591 0.781 1.033 
uVolW 0.665 0.886 1.180 0.876 1.155 1.523 0.763 1.007 1.328 0.588 0.776 1.024 
uLeu 0.751 1.227 2.005 0.589 0.947 1.522 0.527 0.848 1.364 0.622 1.000 1.608 
uOsmoll 0.840 1.081 1.392 0.659 0.841 1.073 0.785 1.002 1.279 0.943 1.203 1.536 
uKeton 0.782 1.134 1.646 0.737 1.056 1.514 0.633 0.907 1.300 0.633 0.907 1.300 
upH 0.689 0.882 1.130 0.915 1.162 1.476 0.749 0.951 1.208 0.730 0.928 1.179 
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Figure 9 95% confidence intervals for the ratio of NK11- and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 10 95% confidence intervals for the ratio of NK33- and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 11 95% confidence intervals for the ratio of NK11+ and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 12 95% confidence intervals for the ratio of NK33+ and the Control feed for males with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 13 95% confidence intervals for the ratio of NK11- and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 14 95% confidence intervals for the ratio of NK33- and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 15 95% confidence intervals for the ratio of NK11+ and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). Endpoints 
labelled with a golden background have a large residual variance compared to the 
historical studies (VR>150%). 
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Figure 16 95% confidence intervals for the ratio of NK33+ and the Control feed for females with 
added intervals for the equivalence limits (blue and red bars, see text). 
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Figure 17 Residual variance (sig2F or 𝝈𝝈𝑭𝑭𝟐𝟐) in the current G-TwYST A study as a percentage of the 
residual variance (sig2E or 𝝈𝝈𝑬𝑬𝟐𝟐) in the historical GRACE studies for males (top panel) and 
females (bottom panel). 
3.2 Equivalence testing using target effect sizes 
90% confidence intervals for 7 variables, with equivalence limits according to the targeted effect 
sizes in Hong et al. (2017), are given in Figure 18 for males and in Figure 19 for females. Note that 
these are 90% intervals, rather than the 95% intervals in Figure 9 to Figure 16. In all cases the null 
hypothesis of non-equivalence is rejected with a p-value smaller than 0.01 (Table 11).  
Table 11 P-values of equivalence tests for the ratio of the mean of the GMO feed versus the mean 
of the control feed using targeted effect sizes of Hong et al. (2017) as equivalence limits. 
P-values smaller than 0.01/0.05 have a gold/yellow background. 
Variable 
Males Females 
NK11- NK33- NK11+ NK33+ NK11- NK33- NK11+ NK33+ 
Weight_27 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
WBC 0.000 0.047 0.015 0.000 0.000 0.000 0.000 0.000 
LYMA 0.000 0.031 0.020 0.001 0.001 0.000 0.000 0.000 
ALP 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Crea 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
Urea 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
CHOL 0.000 0.000 0.000 0.000 0.000 0.000 0.000 0.000 
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Figure 18 90% confidence intervals for the ratio of the mean of the GMO feed and the control feed 
for selected variables for males along with equivalence intervals defined by targeted 
effect sizes of Hong et al. (2017). 
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Figure 19 90% confidence intervals for the ratio of the mean of the GMO feed and the control feed 
for selected variables for females along with equivalence intervals defined by targeted 
effect sizes of Hong et al. (2017). 
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3.3 Classical statistical analysis 
A classical analysis of variance was performed on the cage means after log transforming the data. 
Note that the ANOVA residuals were already assessed by means of a normal probability plot 
(Appendix 5) and a plot of residuals versus fitted values (Appendix 6). Table 12 (males) and Table 13 
(females) present the results of the t-tests, of Dunnett’s tests and of Wilcoxon tests for the 36 
variables divided in four groups. For ease of interpretation results are expressed as means and 
coefficients of variation on the original scale, rather than as means and standard deviations on the 
log scale. Note however that 95% confidence intervals on the ratio scale are given in Table 9 (males) 
and Table 10 (females).  
Results of the t-test and Dunnett’s test for the difference are summarized by letters which indicate 
significance at 5% and at 1%. Results for the non-parametric Wilcoxon test, where each test only uses 
data for the specific GM feed and the non-GM Control feed, are summarized in the same way. Exact 
p-values for these tests are given in Appendix 9. 
It can be seen (Table 12 and Table 13) that the relative precision of variables ranges from high to low 
precision. For example CVs smaller than 5% are observed for most haematology variables, while CVs 
larger than 50% are found for Monocytes, Eosinophils, cHGB, uLeu and uKeton. For some variables 
there is a difference in precision for males and females, e.g. growthRate for males has a CV in the 
range 10-13%, while for females the range equals 42-61%. 
In 20 cases (6.2% of the 320 comparisons) a difference was significant in at least one of the tests at 
the 5% level. On their own, Dunnett’s test resulted in 3 significant differences (0.9%), the t-test 
resulted in 14 significant differences (4.4%), and Wilcoxon’s test resulted in 14 significant differences 
(4.4%). Note that cells coloured red in Table 9 and Table 10, with 95% confidence intervals for ratios, 
correspond to cells coloured red in Table 12 and Table 13 with letters “t”, “T”, “d” or “D”. 
Results of the Shapiro-Wilks test for normality and Bartlett’s and Levene’s test for homogeneity of 
variance are given in Appendix 10. Bartlett’s’ test is significant at the 5% level for males for 3 
variables (FeedMean, MCV, PLT) and for females for 5 variables (HGB, MCHC, Eosinophils, BIL and 
Crea). Levene’s test is significant for male variable WBC, and for females for 4 variables (HGB, BIL, 
Crea, uLeu). This implies that the important assumption of homogeneity of variance is generally 
fulfilled. For these significant cases, one might resort to Wilcoxon’s’ test which is significant for 
FeedMean in males (NK11- and NK33-). 
The Shapiro-Wilks test for non-normality for separate feeding groups (Appendix 10) is frequently 
significant. However the normality assumptions is not very important. Moreover normal probability 
plots (Appendix 5) and plots of residuals versus fitted values (Appendix 6) were generally satisfactory. 
Also, graphs of cage means on the log scale in Appendix 4 indicate that significance of non-normality 
seems mostly due to one outlying observation in a feeding group. 
3.4 Standardized effect sizes 
SES intervals were calculated for all 40 variables. Results for the four treatment groups, separately 
for males and females, are given in Figure 20 to Figure 23. The number of intervals that extend 
outside the -/+ 1 SD limits equals 102 out of 320 (32%). 
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Table 12 Means and coefficient of variation (CV) for male rats. Means of GM feeds which are significantly different from the non-GM Control feed are 
marked, with red background colouring, as follows: D: P<0.01 by Dunnett-test, d: P<0.05 by Dunnett-test, T: P<0.01 by t-test but not by 
Dunnett-test, t: P<0.05 by t-test but not by Dunnett-test, W: P<0.01 by Wilcoxon signed rank test, w: P<0.05 by Wilcoxon signed rank test. 
Dunnett- and t-tests are based on an ANOVA with 5 treatment groups, while Wilcoxon tests only uses data for the specific GM feed and the 
control feed. 
Weights Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Weight_27 500.4 6.0 493.3 7.6  497.1 8.0  495.6 7.4  502.9 7.4  
growthRate 1.603 9.7 1.594 10.8  1.604 11.4  1.572 11.3  1.630 12.7  
FeedMean 19.95 3.7 19.58 6.5 w 19.53 6.5 w 19.68 5.9  20.29 6.5  
Haematology Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
WBC 9.12 17.8 8.87 21.9  10.81 17.4 dTw 10.48 17.6 t 9.61 20.1  
RBC 8.459 4.0 8.487 3.7  8.466 3.3  8.451 3.3  8.525 3.0  
HGB 15.65 3.3 15.72 3.6  15.83 3.3  15.63 3.1  15.92 2.7  
HCT 45.84 3.4 46.01 3.1  46.19 3.6  45.63 3.2  46.39 2.7  
MCV 53.96 1.4 54.27 2.7  54.61 2.7  54.03 2.1  54.46 1.8  
MCH 18.52 3.3 18.55 4.4  18.73 3.4  18.52 2.9  18.70 2.8  
MCHC 34.15 1.8 34.16 2.3  34.30 1.8  34.28 2.1  34.33 1.6  
PLT 829.3 5.3 811.8 13.0  871.5 10.1  863.8 7.7  865.3 12.9  
LYMR 71.41 6.3 69.87 7.0  70.55 8.6  71.51 8.5  72.33 5.5  
LYMA 6.518 17.9 6.192 21.6  7.532 17.7 tw 7.467 18.4 t 6.985 23.9  
diffWBC Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Lymphocytes 69.65 7.5 70.80 6.4  68.72 7.7  70.05 9.3  71.34 6.1  
Neutrophils 26.95 18.0 26.14 15.4  27.43 19.3  26.33 22.0  25.11 15.9  
Monocytes 1.200 40.9 0.899 43.7 tw 1.100 46.9  0.987 50.3 tw 1.025 35.3  
Eosinophils 2.200 54.5 2.161 60.4  2.750 45.3  2.638 62.6  2.525 33.5  
ClinChem Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
ALP 1.386 21.7 1.442 24.8  1.336 22.8  1.352 17.6  1.371 24.5  
ALT 0.679 12.7 0.695 23.4  0.703 21.8  0.675 17.8  0.691 14.5  
AST 2.092 19.7 2.154 19.4  2.253 18.6  2.154 15.0  2.111 14.8  
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BIL 7.325 17.5 7.543 19.8  8.338 25.8 t 7.985 20.2  7.830 16.4 w 
ALB 35.04 3.5 34.99 3.8  35.26 3.8  35.22 3.8  35.20 3.8  
TP 64.58 3.1 64.28 2.5  64.40 2.7  65.00 2.3  64.37 2.8  
Glu 5.944 13.7 5.785 13.5  5.869 12.7  6.040 12.8  6.192 9.2  
CHOL 2.204 12.2 2.264 10.1  2.235 12.7  2.207 12.4  2.289 13.3  
TAG 1.239 40.0 1.293 37.4  1.334 35.4  1.387 38.1 tw 1.296 33.5  
Crea 42.27 8.7 40.97 9.2  41.83 9.5  42.37 8.3  40.77 9.2  
Urea 5.160 11.8 5.017 14.9  5.161 11.5  5.190 11.5  5.099 10.0  
cHGB 63.62 36.3 82.37 72.0  84.32 58.1  82.55 49.2  72.22 43.6  
Ca 2.524 1.7 2.521 1.9  2.538 2.2  2.535 2.2  2.521 1.9  
Cl 101.7 1.3 101.7 1.4  101.2 1.4  101.5 1.2  101.5 1.2  
K 5.057 6.3 5.167 11.5  5.245 8.7  5.325 9.0 t 5.132 7.1  
Na 143.5 1.3 143.8 1.6  143.6 1.2  143.7 1.2  143.0 1.0  
P 2.042 12.6 1.991 13.5  2.051 9.6  2.088 10.1  2.017 9.0  
Urine Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
uVol 20.50 18.6 21.40 13.3  16.75 31.4 t 18.95 30.1  21.35 21.8  
uVolW 4.162 20.2 4.379 14.0  3.381 27.0  3.951 34.8  4.302 20.7  
uLeu 42.50 69.6 32.50 68.3  80.00 102.1  57.50 133.7  38.75 59.8  
uOsmoll 420.2 20.1 379.1 15.2  520.8 24.7  466.4 29.0  405.0 20.9  
uKeton 0.725 131.5 0.475 100.6  0.725 73.5  0.475 114.9  0.325 145.3  
upH 6.825 4.9 6.725 3.3  6.725 2.7  6.850 3.1  6.675 5.3  
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Table 13 Means and coefficient of variation (CV) for female rats. Means of GMO feeds which are significantly different from the Control feed are 
marked, with red background colouring, as follows: D: P<0.01 by Dunnett-test, d: P<0.05 by Dunnett-test, T: P<0.01 by t-test but not by 
Dunnett-test, t: P<0.05 by t-test but not by Dunnett-test, W: P<0.01 by Wilcoxon signed rank test, w: P<0.05 by Wilcoxon signed rank test. 
Note that Dunnett- and t-tests are based on a ANOVA with 5 treatment groups, while Wilcoxon tests only uses data for the specific GM feed 
and the control feed. 
Weights Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Weight_27 271.8 7.0 270.2 7.0  269.5 6.4  269.3 7.7  270.6 7.2  
growthRate 0.587 42.0 0.620 50.5  0.553 61.3  0.549 58.2  0.606 50.8  
FeedMean 14.22 6.1 14.30 8.3  14.36 7.3  14.31 7.9  14.65 8.0  
Haematology Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
WBC 5.865 23.1 5.968 15.8  6.120 27.9  5.590 22.6  6.050 21.5  
RBC 7.657 3.9 7.641 3.2  7.707 3.9  7.678 2.5  7.725 3.6  
HGB 15.58 2.8 15.42 3.4  15.48 1.9  15.39 1.9  15.53 2.6  
HCT 44.14 3.5 44.02 3.3  44.31 2.3  44.05 2.0  44.15 3.2  
MCV 57.68 1.7 57.64 1.6  57.39 2.0  57.41 1.4  57.19 1.7  
MCH 20.37 2.5 20.22 2.6  20.11 3.4  20.07 2.5  20.12 3.2  
MCHC 35.31 2.1 35.08 2.2  34.93 1.2  34.94 1.7  35.20 2.5  
PLT 842.8 9.7 793.9 7.9  812.1 8.4  786.2 11.7 t 819.3 14.3  
LYMR 72.35 5.4 71.22 5.7  71.64 7.3  72.19 5.4  71.13 7.4  
LYMA 4.207 20.3 4.262 17.6  4.348 27.8  4.033 23.4  4.282 24.2  
diffWBC Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
Lymphocytes 67.67 6.3 67.46 6.4  67.40 5.8  67.45 5.2  69.30 6.5  
Neutrophils 28.97 14.7 29.54 13.8  29.61 14.0  29.26 12.9  27.91 15.5  
Monocytes 1.125 53.7 0.851 75.4  1.012 60.7  0.938 38.6  0.662 59.1 dW 
Eosinophils 2.238 33.9 2.213 38.7  1.975 49.6  2.337 33.0  2.125 58.0  
ClinChem Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
ALP 0.649 19.8 0.609 22.7  0.626 26.3  0.616 20.9  0.613 25.4  
ALT 0.623 22.4 0.615 20.4  0.639 18.6  0.548 18.1 tw 0.610 15.1  
AST 1.954 18.3 1.841 18.5  2.107 26.8  1.814 16.4 w 2.086 19.1  
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BIL 8.365 14.4 8.342 9.3  8.755 23.0  8.242 18.2  8.355 15.7  
ALB 41.51 4.6 41.82 5.4  42.03 7.0  42.41 6.0  41.28 6.5  
TP 69.58 3.7 69.67 3.9  70.18 5.0  70.21 3.9  69.10 3.4  
Glu 5.545 12.1 5.370 14.1  5.261 11.5  5.448 13.6  5.485 13.6  
CHOL 2.225 19.0 2.164 18.9  2.063 20.2  2.012 15.7  2.100 16.6  
TAG 0.824 29.1 0.846 47.6  0.744 23.4  0.743 27.5 w 0.781 24.0  
Crea 43.26 16.8 42.52 11.4  41.53 9.3  43.70 15.5  43.51 8.0  
Urea 5.523 10.0 5.765 9.3  5.636 9.8  5.497 7.6  5.679 8.6  
cHGB 75.15 29.5 77.00 20.7  92.51 61.1  84.84 62.7  71.78 24.5  
Ca 2.533 1.8 2.537 2.8  2.557 2.8  2.550 2.6  2.525 2.0  
Cl 101.2 1.6 101.8 1.4  101.9 1.6  101.8 1.5  101.2 1.8  
K 4.175 7.7 4.218 6.8  4.560 12.6 DW 4.318 7.2  4.192 8.3  
Na 142.4 1.6 142.4 1.4  142.2 1.4  142.4 1.4  142.5 1.5  
P 1.344 16.0 1.331 17.1  1.407 18.2  1.350 19.0  1.289 12.0  
Urine Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
uVol 16.75 23.6 16.80 35.7  20.45 27.4  17.75 35.3  13.00 22.9  
uVolW 6.343 25.0 6.233 31.9  7.675 30.0  6.594 34.4  4.922 22.6 w 
uLeu 16.25 102.9 26.25 129.8  15.00 129.1  12.50 124.7  16.25 89.2  
uOsmoll 380.6 25.9 409.1 32.1  326.8 25.5  404.4 47.7  448.4 24.0  
uKeton 0.200 184.5 0.250 182.6  0.225 133.0  0.125 194.4  0.125 194.4  
upH 6.375 2.8 6.250 4.2  6.525 3.4  6.325 5.9  6.300 2.5  
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Figure 20 Confidence intervals for Standardized Effect Sized (SES) for male rats for GMO feeds 
NK11- and NK33- versus the control feed. 
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Figure 21 Confidence intervals for Standardized Effect Sized (SES) for male rats for GMO feeds 
NK11+ and NK33+ versus the control feed. 
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Figure 22 Confidence intervals for Standardized Effect Sized (SES) for female rats for GMO feeds 
NK11- and NK33- versus the control feed. 
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Figure 23 Confidence intervals for Standardized Effect Sized (SES) for female rats for GMO feeds 
NK11+ and NK33+ versus the control feed. 
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3.5 Factorial analysis 
The significance results from fitting the factorial model to the 40 variables are given in Table 14. The 
ratios for the significant cases are shown in Table 15 and Table 16. 
As an example, consider the results for Monocytes. The main GMO effect was significant for males, 
while the interaction is significant for females. The mean of the four GM feeds had a value which is 
82% of the control non-GM feed; note however that in this case there was also a slight indication of a 
GM inclusion rate effect (p=0.083). For Monocytes in females the effect of GM inclusion rate was 
positive for GM feeds without Roundup, while it was negative for GM feeds with Roundup. The only 
main significant GM inclusion rate effect larger than 10% was observed for AST in females. None of 
the significant Roundup main effects was larger than 10%.  
The p-values in Table 14 can be summarized as follows. In 1 out of 80 cases (1.2%) there was a 
significant difference at the 5% level between the mean of the GM feeds and the non-GM feed. In 10 
cases (12.5%) there was a significant interaction term at the 5% level. In these latter cases the main 
effects should not be used for assessing effects of GM inclusion rate or Roundup. Among the 
remaining 70 cases, i.e. where the interaction is not significant, there were 2 cases (2.9%) with a 
significant differences between GM inclusion rates, and 3 cases (4.3%) with a significant difference 
between the GM feeds with and without roundup.  
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Table 14  P values for significance of effects obtained with the factorial model. P-values smaller 
than 0.01/0.05 have a gold/yellow background. 
Response Males Females 
Weights GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
Weight_27 0.433 0.234 0.329 0.677 0.440 0.890 0.976 0.642 
growthRate 0.912 0.191 0.948 0.342 0.916 0.909 0.833 0.162 
FeedMean 0.272 0.100 0.009 0.051 0.342 0.205 0.365 0.397 
Haematology GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
WBC 0.097 0.126 0.419 0.000 0.792 0.472 0.421 0.348 
RBC 0.750 0.685 0.850 0.489 0.626 0.368 0.629 0.900 
HGB 0.290 0.066 0.950 0.438 0.219 0.315 0.993 0.535 
HCT 0.525 0.142 0.797 0.355 0.986 0.507 0.812 0.723 
MCV 0.167 0.163 0.516 0.862 0.242 0.260 0.301 0.923 
MCH 0.542 0.224 0.871 0.961 0.091 0.794 0.556 0.474 
MCHC 0.476 0.545 0.611 0.778 0.111 0.732 0.710 0.170 
PLT 0.471 0.166 0.300 0.083 0.065 0.149 0.896 0.759 
LYMR 0.706 0.439 0.100 0.896 0.397 0.662 0.748 0.347 
LYMA 0.160 0.098 0.166 0.001 0.939 0.698 0.415 0.475 
diffWBC GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
Lymphocytes 0.605 0.731 0.386 0.085 0.686 0.338 0.296 0.190 
Neutrophils 0.510 0.949 0.229 0.233 0.861 0.514 0.291 0.269 
Monocytes 0.034 0.083 0.969 0.722 0.074 0.390 0.743 0.027 
Eosinophils 0.335 0.102 0.750 0.603 0.571 0.083 0.605 0.747 
ClinChem GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
ALP 0.685 0.441 0.805 0.288 0.090 0.866 0.725 0.968 
ALT 0.903 0.465 0.560 0.743 0.445 0.031 0.038 0.248 
AST 0.364 0.732 0.424 0.391 0.970 0.004 0.656 0.687 
BIL 0.067 0.286 0.928 0.139 0.821 0.487 0.224 0.969 
ALB 0.706 0.630 0.736 0.580 0.560 0.326 0.885 0.154 
TP 0.869 0.487 0.363 0.311 0.801 0.626 0.714 0.148 
Glu 0.905 0.416 0.049 0.752 0.204 0.856 0.229 0.684 
CHOL 0.468 0.722 0.836 0.269 0.125 0.786 0.500 0.177 
TAG 0.075 0.839 0.605 0.213 0.268 0.869 0.825 0.151 
Crea 0.276 0.576 0.786 0.095 0.883 0.658 0.091 0.453 
Urea 0.643 0.742 0.556 0.242 0.322 0.927 0.374 0.126 
cHGB 0.057 0.726 0.719 0.226 0.550 0.996 0.135 0.407 
Ca 0.662 0.913 0.890 0.122 0.492 0.837 0.412 0.068 
Cl 0.540 0.442 0.872 0.338 0.093 0.352 0.200 0.159 
K 0.153 0.584 0.685 0.130 0.067 0.312 0.086 0.006 
Na 0.905 0.115 0.222 0.418 0.891 0.707 0.661 0.432 
P 0.935 0.969 0.437 0.110 0.940 0.873 0.166 0.271 
Urine GMO InclRate Roundup Interact GMO InclRate Roundup Interact 
uVol 0.513 0.301 0.545 0.006 0.643 0.938 0.159 0.006 
uVolW 0.583 0.250 0.592 0.011 0.590 0.982 0.150 0.007 
uLeu 0.679 0.265 0.424 0.065 0.981 0.769 0.328 0.189 
uOsmoll 0.607 0.290 0.701 0.006 0.803 0.676 0.090 0.011 
uKeton 0.793 0.845 0.277 0.277 0.978 0.771 0.126 0.771 
upH 0.375 0.287 0.646 0.287 0.780 0.125 0.352 0.067 
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Table 15 Ratios for significant variables at the 5% level in the factorial analysis for males. Main 
effects are “GM vs Contrl” (ratio of the mean of the four GM feeds vs the control feed), 
“33 vs 11” (ratio of the two GM feeds with 33% GM inclusion rate vs the two feeds with 
11% GM inclusion rate) and “+RU vs -RU“ (ratio of the two GM feeds with roundup vs 
the two feeds without roundup). The interaction ratios are scaled such that NK11- 
equals 1. The InclRate and RndUp main effects are only given when the interaction is not 
significant. 
Males 
Group Variable 
GM vs 
Contrl 
33 vs 
11 
+RU vs 
-RU 
Interaction 
NK11- NK33- NK11+ NK33+ 
Weights FeedMean - - 1.02 - - - - 
Haematology WBC - - - 1.00 1.24 1.20 1.10 
Haematology LYMA - - - 1.00 1.24 1.23 1.14 
diffWBC Monocytes 0.82 - - - - - - 
ClinChem Glu - - 1.05 - - - - 
Urine uVol - - - 1.00 0.75 0.85 0.97 
Urine uVolW - - - 1.00 0.75 0.85 0.95 
Urine uOsmoll - - - 1.00 1.32 1.19 1.05 
 
Table 16 Ratios for significant variables at the 5% level in the factorial analysis for females. Main 
effects are “GM vs Contrl” (ratio of the mean of the four GM feeds vs the control feed), 
“33 vs 11” (ratio of the two GM feeds with 33% GM inclusion rate vs the two feeds with 
11% GM inclusion rate) and “+RU vs -RU“ (ratio of the two GM feeds with roundup vs 
the two feeds without roundup). The interaction ratios are scaled such that NK11- 
equals 1. The InclRate and RndUp main effects are only given when the interaction is not 
significant. 
Females 
Group Variable 
GM vs 
Contrl 
33 vs 
11 
+RU vs 
-RU 
Interaction 
NK11- NK33- NK11+ NK33+ 
diffWBC Monocytes - - - 1.00 1.16 1.22 0.88 
ClinChem ALT - 1.08 0.93 - - - - 
ClinChem AST - 1.13 - - - - - 
ClinChem K - - - 1.00 1.06 1.02 0.99 
Urine uVol - - - 1.00 1.32 1.15 0.88 
Urine uVolW - - - 1.00 1.30 1.14 0.88 
Urine uOsmoll - - - 1.00 0.78 0.93 1.11 
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Appendix 1. Growth curves per animal pair 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
The feed group and animal numbers are given in the left top corner of the graph, while the estimated 
growth rate, i.e. 𝛾𝛾 = log(𝛽𝛽), is given in the right-bottom corner. 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 1. Growth curves per animal pair (continued) 
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Appendix 2. Feed consumption per cage 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
  
G-TwYST Study A  Statistical report month 6 appendices 
99 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
  
G-TwYST Study A  Statistical report month 6 appendices 
101 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 2. Feed consumption per cage (continued) 
The feed group and cage numbers are given in the left top corner of the graph. 
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Appendix 3. Graphs of cage means on the original scale 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 3. Graphs of cage means on the original scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 4. Graphs of cage means on the log scale (continued) 
Red symbols denote means for feeding groups while the red line denotes the overall mean. 
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Appendix 5. Normal probability plots of residuals after ANOVA 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
  
G-TwYST Study A  Statistical report month 6 appendices 
130 
 
Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 5. Normal probability plots of residuals after ANOVA (continued) 
Residuals are obtained from ANOVA of cage means (log scale). A 99% confidence envelop is added. 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
  
G-TwYST Study A  Statistical report month 6 appendices 
140 
 
Appendix 6. Graphs of residuals versus fitted values after ANOVA (continued) 
Residuals and fitted values are obtained from ANOVA of cage means (after a log transformation). 
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Appendix 7. Estimated differences between GMO feeds and the control feed 
The differences are given along with the residual sums of squares 𝑆𝑆𝑆𝑆𝐹𝐹 based on ANOVA on cage 
means after a log-transform. The degrees of freedom for the residual sums of squares equals 136 for 
Weight_27 and growthRate, 76 for the other Male variables, and 75 for the other Female variables. 
Degrees of freedom are sometimes one less due to an occasional missing cage mean. 
Variable Male rats Female rats 
NK11- NK33- NK11+ NK33+ 𝑆𝑆𝑆𝑆𝐹𝐹  NK11- NK33- NK11+ NK33+ 𝑆𝑆𝑆𝑆𝐹𝐹  
Weight_27 -0.0156 -0.0087 -0.0106 0.0037 0.3063 -0.0055 -0.0081 -0.0095 -0.0046 0.3063 
FeedMean -0.0200 -0.0226 -0.0143 0.0159 0.5671 0.0044 0.0090 0.0050 0.0282 0.5671 
WBC -0.0481 0.1661 0.1365 0.0466 3.0072 0.0357 0.0258 -0.0411 0.0317 3.0072 
RBC 0.0032 0.0010 -0.0008 0.0080 0.0925 -0.0016 0.0063 0.0031 0.0090 0.0925 
HGB 0.0043 0.0118 -0.0007 0.0176 0.0471 -0.0086 -0.0065 -0.0121 -0.0031 0.0471 
HCT 0.0039 0.0077 -0.0043 0.0124 0.0640 -0.0023 0.0041 -0.0016 0.0003 0.0640 
MCV 0.0064 0.0126 0.0022 0.0102 0.0209 -0.0006 -0.0052 -0.0048 -0.0086 0.0209 
MCH 0.0010 0.0112 0.0001 0.0095 0.0614 -0.0070 -0.0132 -0.0152 -0.0124 0.0614 
MCHC 0.0004 0.0043 0.0039 0.0053 0.0284 -0.0062 -0.0107 -0.0105 -0.0032 0.0284 
PLT -0.0300 0.0435 0.0352 0.0269 0.7755 -0.0577 -0.0323 -0.0676 -0.0284 0.7755 
LYMA -0.0713 0.1475 0.1356 0.0609 3.5482 0.0317 0.0157 -0.0416 0.0109 3.5482 
Lymphocytes 0.0174 -0.0131 0.0046 0.0251 0.2152 0.0013 -0.0029 -0.0019 0.0248 0.2152 
Neutrophils -0.0270 0.0175 -0.0273 -0.0673 1.2590 0.0139 0.0271 0.0155 -0.0345 1.2590 
Monocytes -0.2847 -0.1120 -0.2524 -0.1380 17.3790 -0.2697 -0.1222 -0.0660 -0.3943 17.3790 
Eosinophils -0.0199 0.2430 0.0816 0.2185 16.7395 -0.0180 -0.1661 0.0685 -0.1460 16.7395 
ALP 0.0196 -0.0415 -0.0240 -0.0142 2.1969 -0.0756 -0.0807 -0.0612 -0.0690 2.1969 
ALT 0.0060 0.0167 -0.0182 0.0100 1.9698 -0.0110 0.0254 -0.1273 -0.0083 1.9698 
AST 0.0274 0.0677 0.0294 0.0120 2.6691 -0.0447 0.0600 -0.0801 0.0582 2.6691 
BIL 0.0249 0.1110 0.0780 0.0640 1.0709 0.0142 0.0312 -0.0190 0.0002 1.0709 
ALB -0.0020 0.0059 0.0048 0.0042 0.1910 0.0056 0.0105 0.0198 -0.0070 0.1910 
TP -0.0046 -0.0027 0.0064 -0.0033 0.0955 -0.0001 0.0074 0.0084 -0.0068 0.0955 
Glu -0.0274 -0.0151 0.0139 0.0417 0.8544 -0.0405 -0.0543 -0.0219 -0.0166 0.8544 
CHOL 0.0317 0.0132 -0.0006 0.0354 2.2768 -0.0218 -0.0842 -0.0996 -0.0582 2.2768 
TAG 0.0456 0.0845 0.1112 0.0572 3.2769 -0.0146 -0.0887 -0.0913 -0.0327 3.2769 
Crea -0.0323 -0.0134 0.0006 -0.0371 0.6277 -0.0083 -0.0323 0.0107 0.0169 0.6277 
Urea -0.0328 -0.0013 0.0042 -0.0135 0.5733 0.0438 0.0160 -0.0029 0.0284 0.5733 
cHGB 0.1501 0.2185 0.2178 0.0940 4.2963 0.0532 0.0961 0.0176 -0.0262 4.2963 
Ca -0.0011 0.0055 0.0045 -0.0012 0.0334 0.0017 0.0092 0.0064 -0.0031 0.0334 
Cl 0.0002 -0.0039 -0.0017 -0.0012 0.0119 0.0063 0.0077 0.0067 0.0002 0.0119 
K 0.0154 0.0318 0.0479 0.0130 0.4177 0.0168 0.0793 0.0343 0.0049 0.4177 
Na 0.0022 0.0007 0.0014 -0.0033 0.0070 0.0011 -0.0014 0.0004 0.0012 0.0070 
P -0.0286 0.0076 0.0237 -0.0107 1.4864 0.0097 0.0387 0.0006 -0.0384 1.4864 
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Appendix 8. Intervals for equivalence tests 
95% Confidence interval plus estimate for the ratio Δ of a GMO feed versus the control feed, 95% Confidence 
interval plus median for (upper) equivalence limits, and the confidence interval plus median for Δ on the ELSD 
scale. Red background colouring indicates significant differences, green background colouring indicates 
significant equivalences (in all remaining cases equivalence is still more likely than not). 
Males  NK11- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
Weight_27 0.961 0.985 1.009 1.063 1.092 1.131 -0.438 -0.174 0.105 
FeedMean 0.958 0.980 1.003 1.064 1.094 1.170 -0.472 -0.213 0.035 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
WBC 0.851 0.953 1.067 1.456 1.651 2.386 -0.293 -0.090 0.130 
RBC 0.981 1.003 1.026 1.088 1.113 1.147 -0.183 0.031 0.224 
HGB 0.985 1.004 1.024 1.075 1.097 1.144 -0.166 0.045 0.233 
HCT 0.985 1.004 1.024 1.089 1.112 1.148 -0.148 0.037 0.200 
MCV 0.992 1.006 1.021 1.012 1.027 1.041 -0.352 0.240 0.932 
MCH 0.979 1.001 1.024 1.013 1.039 1.063 -1.405 0.027 1.677 
MCHC 0.988 1.000 1.013 1.017 1.029 1.049 -0.461 0.015 0.481 
PLT 0.909 0.970 1.036 1.612 1.778 2.031 -0.151 -0.052 0.063 
LYMA 0.825 0.931 1.051 1.409 1.598 2.228 -0.386 -0.146 0.105 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
Lymphocytes 0.977 1.018 1.060 1.019 1.066 1.121 -1.032 0.297 2.000 
Neutrophils 0.882 0.973 1.075 1.264 1.384 1.600 -0.359 -0.082 0.232 
Monocytes 0.598 0.752 0.947 1.544 1.949 3.308 -0.804 -0.413 -0.075 
Eosinophils 0.698 0.980 1.377 1.798 2.551 5.365 -0.397 -0.020 0.370 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11- lower esti upper lower median upper lower median upper 
ALP 0.929 1.020 1.119 1.315 1.431 1.601 -0.211 0.055 0.289 
ALT 0.934 1.006 1.084 1.167 1.250 1.375 -0.326 0.026 0.362 
AST 0.935 1.028 1.129 1.241 1.353 1.544 -0.229 0.089 0.374 
ALB 0.977 0.998 1.020 1.099 1.124 1.160 -0.190 -0.017 0.168 
TP 0.980 0.995 1.012 1.073 1.091 1.118 -0.213 -0.052 0.133 
Glu 0.908 0.973 1.043 1.288 1.386 1.647 -0.266 -0.081 0.128 
CHOL 0.964 1.032 1.106 1.203 1.297 1.618 -0.145 0.115 0.360 
TAG 0.943 1.047 1.161 1.844 2.213 4.459 -0.072 0.053 0.171 
Crea 0.924 0.968 1.015 1.284 1.364 1.568 -0.237 -0.102 0.047 
Urea 0.913 0.968 1.026 1.192 1.278 1.609 -0.349 -0.125 0.106 
Ca 0.988 0.999 1.010 1.131 1.161 1.237 -0.076 -0.007 0.067 
Cl 0.993 1.000 1.007 1.102 1.124 1.173 -0.057 0.002 0.059 
K 0.969 1.016 1.065 1.205 1.264 1.354 -0.138 0.065 0.241 
Na 0.997 1.002 1.008 1.112 1.136 1.186 -0.026 0.017 0.054 
P 0.914 0.972 1.033 1.159 1.231 1.410 -0.405 -0.132 0.162 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Males  NK33- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
Weight_27 0.967 0.991 1.016 1.063 1.092 1.131 -0.352 -0.097 0.188 
FeedMean 0.955 0.978 1.001 1.064 1.094 1.171 -0.506 -0.243 0.008 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
WBC 1.055 1.181 1.322 1.458 1.652 2.385 0.092 0.320 0.554 
RBC 0.979 1.001 1.024 1.088 1.113 1.147 -0.205 0.009 0.216 
HGB 0.992 1.012 1.032 1.075 1.097 1.144 -0.084 0.124 0.311 
HCT 0.988 1.008 1.028 1.089 1.112 1.149 -0.112 0.072 0.231 
MCV 0.998 1.013 1.027 1.012 1.028 1.042 -0.070 0.472 1.282 
MCH 0.989 1.011 1.034 1.013 1.039 1.063 -0.410 0.308 2.000 
MCHC 0.992 1.004 1.017 1.017 1.030 1.049 -0.299 0.143 0.569 
PLT 0.978 1.044 1.115 1.612 1.778 2.033 -0.039 0.075 0.174 
LYMA 1.027 1.159 1.308 1.411 1.598 2.236 0.053 0.305 0.568 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
Lymphocytes 0.947 0.987 1.028 1.019 1.066 1.121 -2.000 -0.226 2.000 
Neutrophils 0.922 1.018 1.124 1.264 1.383 1.596 -0.262 0.053 0.338 
Monocytes 0.710 0.894 1.125 1.544 1.952 3.276 -0.491 -0.161 0.181 
Eosinophils 0.908 1.275 1.791 1.803 2.545 5.263 -0.104 0.251 0.624 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33- lower esti upper lower median upper lower median upper 
ALP 0.874 0.959 1.053 1.316 1.430 1.599 -0.345 -0.114 0.148 
ALT 0.944 1.017 1.096 1.166 1.250 1.374 -0.273 0.073 0.385 
AST 0.974 1.070 1.176 1.241 1.353 1.543 -0.089 0.220 0.512 
ALB 0.985 1.006 1.028 1.099 1.124 1.159 -0.134 0.050 0.210 
TP 0.981 0.997 1.013 1.073 1.091 1.118 -0.198 -0.031 0.154 
Glu 0.919 0.985 1.055 1.289 1.386 1.646 -0.234 -0.044 0.167 
CHOL 0.946 1.013 1.085 1.204 1.297 1.622 -0.219 0.048 0.294 
TAG 0.981 1.088 1.207 1.844 2.214 4.394 -0.024 0.101 0.224 
Crea 0.941 0.987 1.034 1.284 1.364 1.571 -0.175 -0.042 0.109 
Urea 0.942 0.999 1.059 1.192 1.278 1.611 -0.250 -0.006 0.244 
Ca 0.994 1.005 1.017 1.131 1.161 1.236 -0.037 0.036 0.100 
Cl 0.989 0.996 1.003 1.102 1.124 1.172 -0.083 -0.033 0.024 
K 0.985 1.032 1.082 1.205 1.263 1.353 -0.065 0.135 0.313 
Na 0.995 1.001 1.006 1.112 1.136 1.186 -0.037 0.005 0.045 
P 0.948 1.008 1.071 1.159 1.231 1.412 -0.268 0.035 0.319 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Males  NK11+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
Weight_27 0.965 0.989 1.014 1.063 1.092 1.132 -0.377 -0.118 0.166 
FeedMean 0.963 0.986 1.009 1.064 1.094 1.171 -0.400 -0.153 0.102 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
WBC 1.024 1.146 1.283 1.455 1.650 2.403 0.042 0.262 0.490 
RBC 0.977 0.999 1.022 1.088 1.113 1.147 -0.217 -0.007 0.210 
HGB 0.980 0.999 1.019 1.075 1.097 1.144 -0.216 -0.007 0.208 
HCT 0.976 0.996 1.015 1.089 1.112 1.148 -0.202 -0.040 0.145 
MCV 0.988 1.002 1.017 1.012 1.028 1.041 -0.577 0.086 0.750 
MCH 0.978 1.000 1.023 1.013 1.039 1.063 -1.608 0.007 1.703 
MCHC 0.992 1.004 1.016 1.017 1.030 1.049 -0.313 0.130 0.556 
PLT 0.970 1.036 1.106 1.613 1.777 2.029 -0.053 0.060 0.158 
LYMA 1.015 1.145 1.293 1.410 1.598 2.222 0.031 0.278 0.538 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
Lymphocytes 0.964 1.005 1.047 1.019 1.067 1.120 -2.000 0.079 2.000 
Neutrophils 0.881 0.973 1.074 1.264 1.383 1.598 -0.361 -0.083 0.226 
Monocytes 0.617 0.777 0.978 1.542 1.951 3.286 -0.745 -0.365 -0.031 
Eosinophils 0.772 1.085 1.524 1.803 2.549 5.368 -0.294 0.083 0.431 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK11+ lower esti upper lower median upper lower median upper 
ALP 0.889 0.976 1.072 1.314 1.431 1.599 -0.301 -0.066 0.197 
ALT 0.911 0.982 1.058 1.167 1.250 1.375 -0.389 -0.080 0.265 
AST 0.937 1.030 1.131 1.241 1.353 1.541 -0.221 0.094 0.379 
ALB 0.984 1.005 1.026 1.099 1.124 1.159 -0.142 0.040 0.203 
TP 0.990 1.006 1.023 1.073 1.091 1.118 -0.112 0.073 0.232 
Glu 0.946 1.014 1.087 1.288 1.386 1.647 -0.172 0.042 0.232 
CHOL 0.933 0.999 1.071 1.203 1.297 1.615 -0.276 -0.003 0.274 
TAG 1.007 1.118 1.240 1.845 2.213 4.419 0.008 0.133 0.261 
Crea 0.955 1.001 1.049 1.284 1.363 1.567 -0.153 0.002 0.155 
Urea 0.947 1.004 1.065 1.192 1.278 1.615 -0.230 0.015 0.251 
Ca 0.993 1.005 1.016 1.131 1.161 1.237 -0.044 0.029 0.093 
Cl 0.992 0.998 1.005 1.102 1.124 1.172 -0.065 -0.014 0.044 
K 1.001 1.049 1.100 1.205 1.263 1.353 0.004 0.202 0.386 
Na 0.996 1.001 1.007 1.112 1.136 1.186 -0.032 0.011 0.048 
P 0.963 1.024 1.089 1.159 1.231 1.412 -0.184 0.110 0.381 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Males  NK33+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
Weight_27 0.979 1.004 1.029 1.063 1.092 1.131 -0.248 0.041 0.309 
FeedMean 0.993 1.016 1.040 1.064 1.094 1.172 -0.081 0.170 0.421 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
WBC 0.936 1.048 1.173 1.455 1.651 2.389 -0.133 0.089 0.292 
RBC 0.986 1.008 1.031 1.088 1.113 1.147 -0.136 0.076 0.259 
HGB 0.998 1.018 1.038 1.075 1.097 1.144 -0.019 0.186 0.379 
HCT 0.993 1.012 1.032 1.089 1.112 1.149 -0.066 0.116 0.277 
MCV 0.996 1.010 1.025 1.012 1.028 1.041 -0.171 0.383 1.150 
MCH 0.987 1.010 1.033 1.013 1.039 1.063 -0.501 0.261 2.000 
MCHC 0.993 1.005 1.018 1.017 1.030 1.050 -0.256 0.178 0.607 
PLT 0.962 1.027 1.097 1.613 1.778 2.029 -0.068 0.047 0.145 
LYMA 0.942 1.063 1.200 1.411 1.598 2.224 -0.129 0.124 0.362 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
Lymphocytes 0.984 1.025 1.068 1.019 1.066 1.120 -0.410 0.434 2.000 
Neutrophils 0.847 0.935 1.032 1.263 1.383 1.598 -0.491 -0.203 0.098 
Monocytes 0.692 0.871 1.096 1.544 1.951 3.297 -0.538 -0.198 0.140 
Eosinophils 0.886 1.244 1.748 1.800 2.550 5.276 -0.133 0.225 0.590 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Males NK33+ lower esti upper lower median upper lower median upper 
ALP 0.898 0.986 1.082 1.315 1.430 1.602 -0.281 -0.040 0.226 
ALT 0.937 1.010 1.088 1.166 1.250 1.373 -0.307 0.044 0.368 
AST 0.921 1.012 1.112 1.240 1.353 1.543 -0.285 0.038 0.336 
ALB 0.983 1.004 1.026 1.099 1.124 1.159 -0.149 0.035 0.198 
TP 0.981 0.997 1.013 1.073 1.091 1.118 -0.202 -0.038 0.148 
Glu 0.973 1.043 1.117 1.288 1.386 1.649 -0.083 0.124 0.314 
CHOL 0.967 1.036 1.110 1.203 1.297 1.619 -0.129 0.128 0.375 
TAG 0.954 1.059 1.175 1.843 2.213 4.398 -0.057 0.068 0.186 
Crea 0.919 0.964 1.010 1.284 1.363 1.569 -0.252 -0.117 0.032 
Urea 0.930 0.987 1.046 1.191 1.278 1.619 -0.272 -0.051 0.189 
Ca 0.988 0.999 1.010 1.131 1.161 1.237 -0.076 -0.008 0.066 
Cl 0.992 0.999 1.006 1.102 1.124 1.171 -0.062 -0.011 0.047 
K 0.966 1.013 1.062 1.205 1.263 1.353 -0.149 0.055 0.233 
Na 0.991 0.997 1.002 1.112 1.136 1.186 -0.063 -0.025 0.017 
P 0.930 0.989 1.052 1.158 1.231 1.415 -0.326 -0.049 0.254 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK11- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
Weight_27 0.972 0.994 1.017 1.097 1.125 1.174 -0.214 -0.046 0.145 
FeedMean 0.974 1.004 1.035 1.067 1.108 1.204 -0.269 0.040 0.331 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
WBC 0.912 1.036 1.178 1.496 1.698 2.264 -0.174 0.065 0.278 
RBC 0.976 0.998 1.021 1.053 1.076 1.123 -0.321 -0.021 0.296 
HGB 0.976 0.991 1.008 1.051 1.067 1.095 -0.346 -0.129 0.112 
HCT 0.979 0.998 1.017 1.038 1.056 1.091 -0.366 -0.042 0.310 
MCV 0.989 0.999 1.010 1.031 1.041 1.055 -0.274 -0.016 0.257 
MCH 0.975 0.993 1.011 1.045 1.062 1.085 -0.388 -0.115 0.191 
MCHC 0.981 0.994 1.006 1.013 1.026 1.038 -0.797 -0.243 0.271 
PLT 0.884 0.944 1.007 1.363 1.465 1.629 -0.299 -0.149 0.016 
LYMA 0.898 1.032 1.186 1.433 1.633 2.132 -0.221 0.062 0.319 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
Lymphocytes 0.968 1.001 1.036 1.056 1.092 1.158 -0.404 0.015 0.421 
Neutrophils 0.933 1.014 1.102 1.360 1.487 1.853 -0.173 0.034 0.222 
Monocytes 0.561 0.764 1.039 1.115 1.421 2.875 -2.000 -0.781 0.099 
Eosinophils 0.726 0.982 1.329 2.064 2.717 4.250 -0.313 -0.018 0.292 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11- lower esti upper lower median upper lower median upper 
ALP 0.831 0.927 1.035 1.192 1.320 1.480 -0.660 -0.270 0.120 
ALT 0.892 0.989 1.097 1.576 1.757 2.062 -0.188 -0.019 0.163 
AST 0.847 0.956 1.079 1.331 1.482 1.720 -0.385 -0.112 0.193 
ALB 0.974 1.006 1.039 1.181 1.225 1.286 -0.130 0.027 0.167 
TP 0.977 1.000 1.023 1.157 1.198 1.326 -0.125 -0.001 0.124 
Glu 0.897 0.960 1.028 1.289 1.380 1.539 -0.309 -0.124 0.083 
CHOL 0.875 0.978 1.094 1.065 1.204 1.387 -2.000 -0.122 0.982 
TAG 0.862 0.985 1.127 1.824 2.116 2.808 -0.183 -0.019 0.159 
Crea 0.935 0.992 1.052 1.255 1.345 1.670 -0.207 -0.026 0.170 
Urea 0.988 1.045 1.105 1.237 1.332 1.730 -0.037 0.144 0.328 
Ca 0.988 1.002 1.015 1.124 1.168 1.369 -0.075 0.010 0.090 
Cl 0.998 1.006 1.014 1.056 1.068 1.086 -0.025 0.095 0.200 
K 0.969 1.017 1.067 1.205 1.268 1.426 -0.128 0.068 0.242 
Na 0.995 1.001 1.007 1.054 1.066 1.092 -0.078 0.017 0.101 
P 0.923 1.010 1.105 1.166 1.272 1.471 -0.356 0.038 0.408 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK33- versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33- lower esti upper lower median upper lower median upper 
Weight_27 0.970 0.992 1.014 1.097 1.125 1.174 -0.234 -0.068 0.121 
FeedMean 0.979 1.009 1.040 1.067 1.108 1.204 -0.222 0.082 0.371 
    
Females NK33- lower esti upper lower median upper lower median upper 
WBC 0.904 1.026 1.164 1.497 1.698 2.252 -0.193 0.047 0.263 
RBC 0.984 1.006 1.029 1.053 1.076 1.123 -0.223 0.082 0.360 
HGB 0.978 0.994 1.009 1.051 1.067 1.094 -0.313 -0.097 0.144 
HCT 0.986 1.004 1.023 1.038 1.056 1.091 -0.274 0.073 0.389 
MCV 0.984 0.995 1.005 1.031 1.041 1.055 -0.363 -0.128 0.138 
MCH 0.969 0.987 1.005 1.044 1.062 1.085 -0.497 -0.217 0.083 
MCHC 0.977 0.989 1.002 1.013 1.026 1.038 -1.032 -0.420 0.069 
PLT 0.908 0.968 1.032 1.363 1.466 1.628 -0.230 -0.084 0.083 
LYMA 0.886 1.016 1.165 1.433 1.634 2.136 -0.257 0.031 0.297 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33- lower esti upper lower median upper lower median upper 
Lymphocytes 0.964 0.997 1.031 1.056 1.092 1.158 -0.423 -0.032 0.380 
Neutrophils 0.947 1.027 1.115 1.361 1.487 1.859 -0.138 0.066 0.247 
Monocytes 0.653 0.885 1.198 1.117 1.624 2.850 -2.000 -0.344 2.000 
Eosinophils 0.629 0.847 1.141 2.063 2.719 4.267 -0.436 -0.164 0.134 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33- lower esti upper lower median upper lower median upper 
ALP 0.828 0.922 1.027 1.192 1.320 1.481 -0.681 -0.289 0.098 
ALT 0.926 1.026 1.136 1.577 1.758 2.063 -0.136 0.045 0.203 
AST 0.943 1.062 1.196 1.331 1.482 1.720 -0.153 0.150 0.427 
ALB 0.979 1.011 1.043 1.181 1.225 1.286 -0.106 0.051 0.186 
TP 0.985 1.007 1.030 1.157 1.198 1.321 -0.083 0.039 0.148 
Glu 0.886 0.947 1.013 1.289 1.380 1.539 -0.355 -0.167 0.041 
CHOL 0.824 0.919 1.026 1.065 1.196 1.382 -2.000 -0.474 0.169 
TAG 0.802 0.915 1.044 1.827 2.115 2.791 -0.273 -0.116 0.056 
Crea 0.914 0.968 1.026 1.255 1.345 1.674 -0.280 -0.104 0.083 
Urea 0.962 1.016 1.074 1.238 1.332 1.734 -0.138 0.052 0.226 
Ca 0.996 1.009 1.023 1.124 1.168 1.369 -0.025 0.055 0.137 
Cl 1.000 1.008 1.016 1.056 1.068 1.086 -0.004 0.115 0.223 
K 1.033 1.082 1.135 1.205 1.268 1.420 0.125 0.327 0.527 
Na 0.993 0.999 1.005 1.054 1.066 1.093 -0.104 -0.020 0.074 
P 0.951 1.039 1.136 1.166 1.272 1.468 -0.217 0.157 0.511 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK11+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
Weight_27 0.969 0.991 1.013 1.097 1.126 1.174 -0.245 -0.079 0.111 
FeedMean 0.975 1.005 1.036 1.067 1.108 1.204 -0.262 0.047 0.338 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
WBC 0.846 0.960 1.089 1.497 1.698 2.242 -0.287 -0.076 0.163 
RBC 0.981 1.003 1.026 1.053 1.076 1.122 -0.270 0.040 0.328 
HGB 0.973 0.988 1.004 1.051 1.067 1.094 -0.401 -0.182 0.057 
HCT 0.980 0.998 1.017 1.038 1.056 1.091 -0.365 -0.029 0.326 
MCV 0.985 0.995 1.006 1.031 1.041 1.055 -0.354 -0.118 0.144 
MCH 0.967 0.985 1.003 1.044 1.062 1.085 -0.537 -0.251 0.046 
MCHC 0.977 0.990 1.002 1.013 1.026 1.038 -1.033 -0.418 0.072 
PLT 0.877 0.935 0.997 1.363 1.465 1.628 -0.327 -0.175 -0.009 
LYMA 0.836 0.959 1.100 1.434 1.635 2.147 -0.334 -0.082 0.197 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
Lymphocytes 0.965 0.998 1.032 1.056 1.092 1.157 -0.420 -0.021 0.390 
Neutrophils 0.936 1.016 1.102 1.361 1.486 1.856 -0.168 0.038 0.225 
Monocytes 0.691 0.936 1.268 1.115 1.621 2.855 -2.000 -0.182 2.000 
Eosinophils 0.795 1.071 1.442 2.066 2.717 4.295 -0.238 0.067 0.340 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK11+ lower esti upper lower median upper lower median upper 
ALP 0.845 0.941 1.048 1.191 1.319 1.478 -0.598 -0.218 0.177 
ALT 0.795 0.880 0.975 1.578 1.758 2.059 -0.391 -0.224 -0.044 
AST 0.820 0.923 1.039 1.330 1.482 1.719 -0.482 -0.202 0.098 
ALB 0.988 1.020 1.053 1.181 1.225 1.286 -0.060 0.097 0.232 
TP 0.986 1.008 1.031 1.157 1.198 1.324 -0.079 0.044 0.153 
Glu 0.915 0.978 1.046 1.290 1.380 1.539 -0.250 -0.067 0.142 
CHOL 0.811 0.905 1.010 1.063 1.195 1.384 -2.000 -0.560 0.063 
TAG 0.800 0.913 1.041 1.824 2.116 2.803 -0.275 -0.119 0.054 
Crea 0.954 1.011 1.071 1.255 1.345 1.675 -0.161 0.034 0.211 
Urea 0.944 0.997 1.054 1.238 1.332 1.733 -0.199 -0.009 0.188 
Ca 0.993 1.006 1.020 1.124 1.168 1.368 -0.044 0.038 0.116 
Cl 0.999 1.007 1.015 1.056 1.068 1.086 -0.019 0.100 0.206 
K 0.987 1.035 1.085 1.205 1.268 1.425 -0.053 0.140 0.319 
Na 0.994 1.000 1.006 1.054 1.066 1.092 -0.091 0.005 0.097 
P 0.916 1.001 1.093 1.167 1.272 1.468 -0.395 0.004 0.399 
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Appendix 8. Intervals for equivalence tests (continued) 
 
Females  NK33+ versus Control 
Weights Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
Weight_27 0.973 0.995 1.018 1.097 1.125 1.174 -0.209 -0.038 0.153 
FeedMean 0.998 1.029 1.060 1.067 1.108 1.202 -0.022 0.266 0.586 
Haematology Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
WBC 0.910 1.032 1.171 1.497 1.699 2.250 -0.182 0.058 0.271 
RBC 0.987 1.009 1.032 1.053 1.076 1.123 -0.184 0.121 0.399 
HGB 0.981 0.997 1.013 1.051 1.067 1.094 -0.269 -0.047 0.202 
HCT 0.982 1.000 1.019 1.038 1.056 1.091 -0.351 0.006 0.358 
MCV 0.981 0.991 1.002 1.031 1.041 1.055 -0.453 -0.212 0.046 
MCH 0.970 0.988 1.006 1.044 1.062 1.085 -0.484 -0.204 0.097 
MCHC 0.985 0.997 1.009 1.013 1.026 1.038 -0.661 -0.125 0.420 
PLT 0.912 0.972 1.036 1.362 1.465 1.626 -0.219 -0.074 0.095 
LYMA 0.881 1.011 1.159 1.433 1.634 2.144 -0.265 0.022 0.293 
diffWBC Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
Lymphocytes 0.991 1.025 1.060 1.056 1.092 1.158 -0.102 0.273 0.669 
Neutrophils 0.890 0.966 1.048 1.361 1.487 1.858 -0.267 -0.084 0.119 
Monocytes 0.498 0.674 0.913 1.116 1.420 2.857 -2.000 -1.142 -0.191 
Eosinophils 0.642 0.864 1.164 2.059 2.718 4.252 -0.416 -0.143 0.156 
ClinChem Interval for ratio Δ Interval for EQ limit Interval for Δ ELSD scale 
Females NK33+ lower esti upper lower median upper lower median upper 
ALP 0.838 0.933 1.040 1.192 1.320 1.479 -0.635 -0.246 0.148 
ALT 0.895 0.992 1.098 1.575 1.757 2.064 -0.188 -0.015 0.169 
AST 0.941 1.060 1.194 1.331 1.482 1.721 -0.159 0.146 0.421 
ALB 0.962 0.993 1.025 1.181 1.225 1.286 -0.172 -0.034 0.124 
TP 0.971 0.993 1.016 1.157 1.198 1.325 -0.146 -0.036 0.087 
Glu 0.920 0.984 1.052 1.289 1.380 1.540 -0.236 -0.050 0.161 
CHOL 0.845 0.943 1.053 1.063 1.196 1.386 -2.000 -0.328 0.385 
TAG 0.848 0.968 1.104 1.827 2.116 2.803 -0.197 -0.042 0.135 
Crea 0.960 1.017 1.077 1.255 1.345 1.674 -0.138 0.054 0.226 
Urea 0.974 1.029 1.087 1.237 1.332 1.731 -0.092 0.093 0.270 
Ca 0.984 0.997 1.010 1.124 1.168 1.370 -0.095 -0.018 0.066 
Cl 0.992 1.000 1.008 1.056 1.068 1.087 -0.119 0.003 0.123 
K 0.959 1.005 1.053 1.205 1.268 1.423 -0.181 0.019 0.206 
Na 0.995 1.001 1.007 1.054 1.066 1.093 -0.076 0.018 0.103 
P 0.881 0.962 1.052 1.166 1.272 1.469 -0.509 -0.157 0.218 
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Appendix 9. P-values for difference tests between GMO feeds and the control feed 
Difference tests are based on log transformed cage means. P-values are given for Dunnett tests (Dunnet), for t-tests and for Wilcoxon signed rank tests 
(Wilcox). P-values smaller than 0.01/0.05 have a gold/yellow background. 
Weights NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Weight_27 0.539 0.216 0.245 0.896 0.489 0.441 0.813 0.400 0.533 0.995 0.768 0.840 
growthRate 0.998 0.812 0.680 1.000 0.987 0.994 0.800 0.387 0.225 0.874 0.462 0.599 
FeedMean 0.265 0.091 0.033 0.175 0.057 0.023 0.557 0.226 0.201 0.468 0.180 0.149 
Haematology NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
WBC 0.811 0.399 0.409 0.016 0.004 0.015 0.061 0.018 0.064 0.827 0.414 0.430 
RBC 0.995 0.774 0.784 1.000 0.933 0.648 1.000 0.945 0.812 0.887 0.480 0.729 
HGB 0.978 0.665 0.956 0.568 0.232 0.177 1.000 0.943 0.985 0.224 0.076 0.105 
HCT 0.984 0.690 1.000 0.845 0.431 0.330 0.977 0.662 0.701 0.524 0.209 0.216 
MCV 0.785 0.380 0.465 0.246 0.086 0.080 0.994 0.759 0.984 0.426 0.163 0.055 
MCH 1.000 0.928 0.869 0.717 0.324 0.261 1.000 0.991 0.956 0.814 0.402 0.053 
MCHC 1.000 0.944 0.756 0.892 0.486 0.571 0.922 0.529 0.644 0.803 0.391 0.388 
PLT 0.772 0.366 0.189 0.489 0.191 0.123 0.664 0.289 0.154 0.831 0.417 0.330 
LYMR 0.630 0.268 0.177 0.911 0.512 0.261 1.000 0.975 0.898 0.930 0.543 0.294 
LYMA 0.590 0.245 0.189 0.059 0.018 0.048 0.093 0.029 0.123 0.710 0.319 0.388 
diffWBC NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Lymphocytes 0.816 0.403 0.177 0.920 0.527 0.388 0.998 0.823 0.956 0.561 0.229 0.133 
Neutrophils 0.953 0.588 0.644 0.990 0.725 0.522 0.951 0.584 0.648 0.466 0.180 0.177 
Monocytes 0.054 0.016 0.035 0.733 0.335 0.332 0.102 0.032 0.042 0.575 0.236 0.179 
Eosinophils 1.000 0.907 0.970 0.421 0.158 0.198 0.970 0.634 0.622 0.515 0.204 0.205 
ClinChem NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
ALP 0.981 0.677 0.571 0.787 0.378 0.330 0.961 0.609 0.522 0.994 0.762 0.648 
ALT 1.000 0.873 0.927 0.976 0.657 0.956 0.968 0.628 0.522 0.997 0.791 0.841 
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AST 0.941 0.564 0.729 0.416 0.156 0.202 0.926 0.537 0.245 0.997 0.800 0.648 
BIL 0.958 0.600 0.409 0.072 0.022 0.076 0.294 0.104 0.189 0.468 0.181 0.040 
ALB 0.999 0.852 0.927 0.952 0.586 0.498 0.977 0.658 0.701 0.985 0.695 0.522 
TP 0.945 0.571 0.674 0.991 0.734 0.522 0.840 0.426 0.756 0.982 0.680 0.571 
Glu 0.845 0.432 0.231 0.978 0.664 0.596 0.984 0.690 0.784 0.569 0.233 0.076 
CHOL 0.767 0.362 0.349 0.986 0.703 0.546 1.000 0.987 0.869 0.696 0.309 0.701 
TAG 0.796 0.385 0.097 0.309 0.110 0.245 0.116 0.036 0.024 0.645 0.277 0.261 
Crea 0.460 0.177 0.277 0.946 0.574 0.475 1.000 0.979 0.985 0.336 0.121 0.177 
Urea 0.634 0.270 0.231 1.000 0.965 0.756 1.000 0.888 0.701 0.974 0.647 0.674 
cHGB 0.470 0.182 0.312 0.164 0.054 0.058 0.166 0.054 0.070 0.814 0.402 0.294 
Ca 0.999 0.846 0.985 0.721 0.327 0.294 0.833 0.420 0.368 0.998 0.830 0.522 
Cl 1.000 0.944 0.809 0.601 0.251 0.177 0.965 0.621 0.852 0.989 0.718 0.955 
K 0.915 0.518 0.673 0.473 0.183 0.216 0.146 0.047 0.064 0.951 0.586 0.478 
Na 0.837 0.423 0.398 0.997 0.800 0.784 0.961 0.610 0.596 0.576 0.237 0.260 
P 0.761 0.357 0.452 0.997 0.807 0.388 0.856 0.444 0.430 0.991 0.729 0.841 
Urine NK11- NK33- NK11+ NK33+ 
Males Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
uVol 0.909 0.513 0.322 0.123 0.039 0.193 0.738 0.342 0.695 0.990 0.728 0.846 
uVolW 0.877 0.471 0.275 0.165 0.054 0.160 0.851 0.441 0.846 0.995 0.777 0.922 
uLeu 0.974 0.650 1.000 0.283 0.100 0.175 0.993 0.754 0.461 0.998 0.820 0.796 
uOsmoll 0.807 0.398 0.160 0.178 0.059 0.193 0.769 0.366 0.492 0.988 0.715 0.770 
uKeton 0.996 0.782 0.599 0.917 0.525 0.396 0.996 0.782 0.722 0.766 0.363 0.438 
upH 0.795 0.388 0.254 0.795 0.388 0.279 0.998 0.828 0.903 0.499 0.198 0.396 
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Weights NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Weight_27 0.968 0.628 0.994 0.884 0.474 0.334 0.818 0.404 0.599 0.983 0.683 0.815 
growthRate 0.998 0.812 0.680 1.000 0.987 0.994 0.800 0.387 0.225 0.874 0.462 0.599 
FeedMean 0.996 0.778 0.656 0.941 0.562 0.622 0.993 0.747 0.942 0.210 0.070 0.058 
Haematology NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
WBC 0.950 0.581 0.595 0.983 0.685 0.648 0.915 0.518 0.622 0.965 0.618 0.349 
RBC 1.000 0.890 0.798 0.946 0.573 0.522 0.996 0.783 0.674 0.833 0.418 0.546 
HGB 0.668 0.290 0.196 0.830 0.415 0.368 0.363 0.132 0.103 0.985 0.693 0.648 
HCT 0.997 0.805 0.738 0.976 0.655 0.784 0.999 0.861 0.729 1.000 0.970 0.702 
MCV 1.000 0.906 0.860 0.730 0.332 0.522 0.773 0.365 0.475 0.305 0.108 0.114 
MCH 0.863 0.450 0.352 0.403 0.150 0.097 0.278 0.097 0.231 0.459 0.176 0.388 
MCHC 0.719 0.324 0.258 0.254 0.087 0.165 0.264 0.091 0.070 0.960 0.606 0.841 
PLT 0.240 0.082 0.293 0.709 0.318 0.165 0.123 0.039 0.053 0.790 0.380 0.312 
LYMR 0.759 0.354 0.312 0.937 0.555 0.869 1.000 0.946 0.869 0.697 0.309 0.261 
LYMA 0.975 0.652 0.541 0.998 0.820 0.784 0.933 0.547 0.430 1.000 0.875 0.571 
diffWBC NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
Lymphocytes 1.000 0.939 0.953 0.999 0.863 0.920 1.000 0.910 0.869 0.397 0.147 0.076 
Neutrophils 0.992 0.740 0.595 0.910 0.511 0.430 0.987 0.706 0.701 0.816 0.403 0.277 
Monocytes 0.249 0.085 0.093 0.839 0.424 0.709 0.979 0.666 0.365 0.040 0.012 0.004 
Eosinophils 1.000 0.906 1.000 0.635 0.270 0.205 0.974 0.648 0.481 0.729 0.332 0.588 
ClinChem NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
ALP 0.453 0.173 0.104 0.381 0.140 0.571 0.621 0.262 0.202 0.520 0.206 0.123 
ALT 0.999 0.833 0.623 0.966 0.622 0.674 0.051 0.015 0.021 1.000 0.871 0.898 
AST 0.874 0.463 0.568 0.710 0.318 0.202 0.474 0.183 0.040 0.730 0.332 0.231 
BIL 0.988 0.713 0.738 0.826 0.412 0.729 0.964 0.617 0.522 1.000 0.995 0.841 
ALB 0.991 0.732 0.798 0.912 0.512 0.729 0.544 0.219 0.189 0.978 0.664 0.522 
TP 1.000 0.994 0.798 0.912 0.513 0.522 0.872 0.461 0.261 0.933 0.548 0.430 
Glu 0.585 0.241 0.275 0.315 0.112 0.123 0.916 0.519 0.648 0.967 0.624 0.674 
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CHOL 0.986 0.699 0.798 0.359 0.131 0.261 0.222 0.075 0.058 0.674 0.294 0.368 
TAG 0.998 0.828 0.541 0.475 0.184 0.114 0.450 0.172 0.040 0.966 0.623 0.475 
Crea 0.996 0.780 0.953 0.630 0.267 0.498 0.988 0.712 0.898 0.940 0.561 0.622 
Urea 0.342 0.123 0.196 0.942 0.566 0.812 1.000 0.917 0.571 0.695 0.308 0.812 
cHGB 0.897 0.491 0.258 0.523 0.208 0.648 0.998 0.817 0.674 0.991 0.730 0.674 
Ca 0.997 0.804 0.965 0.447 0.170 0.277 0.742 0.341 0.231 0.973 0.645 0.409 
Cl 0.342 0.123 0.108 0.177 0.058 0.064 0.280 0.097 0.154 1.000 0.960 0.911 
K 0.893 0.486 0.515 0.005 0.001 0.001 0.403 0.150 0.153 0.999 0.836 0.522 
Na 0.990 0.723 0.829 0.976 0.655 0.673 1.000 0.909 0.856 0.984 0.690 0.898 
P 0.998 0.830 0.829 0.800 0.388 0.475 1.000 0.989 0.985 0.804 0.391 0.368 
Urine NK11- NK33- NK11+ NK33+ 
Females Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox Dunnet t-test Wilcox 
uVol 0.808 0.398 0.141 0.615 0.260 0.131 1.000 0.903 0.695 0.236 0.081 0.084 
uVolW 0.807 0.396 0.164 0.677 0.298 0.275 1.000 0.961 0.695 0.212 0.071 0.049 
uLeu 0.815 0.404 0.430 0.998 0.816 0.943 0.891 0.486 0.829 1.000 1.000 0.577 
uOsmoll 0.923 0.533 0.426 0.418 0.158 0.160 1.000 0.987 0.846 0.363 0.133 0.084 
uKeton 0.899 0.497 0.583 0.994 0.759 1.000 0.951 0.587 0.892 0.951 0.587 0.410 
upH 0.694 0.310 0.187 0.528 0.212 0.124 0.980 0.674 1.000 0.920 0.529 0.407 
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Appendix 10. Tests for normality and homogeneity of variance 
P-values for the Shapiro-Wilks (SW) normality test are given separately for each feeding group, and also for the ANOVA residuals. In addition P-values for 
Bartlett and Levene test for homogeneity of variance are given. P-values smaller than 0.01/0.05 have a gold/yellow background. 
Male Weights SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Weight_27 0.776 0.685 0.585 0.158 0.641 0.246 0.545 0.378 
growthRate 0.000 0.684 0.875 0.167 0.415 0.094 0.573 0.133 
FeedMean 0.700 0.478 0.645 0.305 0.436 0.110 0.010 0.059 
Male Haematology SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
WBC 0.991 0.946 0.269 0.079 0.540 0.998 0.912 0.971 
RBC 0.194 0.401 0.624 0.229 0.256 0.214 0.758 0.548 
HGB 0.048 0.001 0.580 0.672 0.388 0.491 0.686 0.908 
HCT 0.284 0.970 0.714 0.322 0.917 0.333 0.754 0.820 
MCV 0.180 0.085 0.965 0.761 0.821 0.908 0.043 0.171 
MCH 0.095 0.536 0.986 0.729 0.267 0.601 0.276 0.285 
MCHC 0.153 0.637 0.928 0.462 0.803 0.560 0.543 0.668 
PLT 0.223 0.037 0.272 0.522 0.753 0.213 0.003 0.088 
LYMR 0.488 0.903 0.790 0.003 0.449 0.951 0.196 0.232 
LYMA 0.349 0.385 0.324 0.058 0.832 0.686 0.843 0.819 
Male diffWBC SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Lymphocytes 0.561 0.284 0.509 0.066 0.925 0.199 0.268 0.713 
Neutrophils 0.715 0.007 0.272 0.668 0.728 0.867 0.790 0.962 
Monocytes 0.374 0.004 0.004 0.037 0.014 0.160 0.196 0.251 
Eosinophils 0.111 0.501 0.043 0.043 0.026 0.004 0.063 0.051 
Male ClinChem SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
ALP 0.476 0.447 0.386 0.146 0.558 0.895 0.755 0.798 
ALT 0.976 0.270 0.621 0.291 0.128 0.015 0.519 0.731 
AST 0.408 0.487 0.847 0.541 0.999 0.570 0.742 0.564 
BIL 0.203 0.609 0.002 0.027 0.360 0.018 0.964 0.986 
ALB 0.416 0.872 0.788 0.527 0.166 0.939 0.998 0.995 
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TP 0.185 0.015 0.268 0.240 0.901 0.749 0.742 0.358 
Glu 0.114 0.752 0.054 0.461 0.651 0.299 0.529 0.475 
CHOL 1.000 0.233 0.991 0.344 0.415 0.578 0.895 0.965 
TAG 0.599 0.212 0.716 0.083 0.914 0.852 0.979 0.903 
Crea 0.126 0.103 0.269 0.952 0.148 0.743 0.983 0.994 
Urea 0.600 0.126 0.332 0.007 0.913 0.872 0.592 0.697 
cHGB 0.855 0.184 0.065 0.160 0.217 0.021 0.439 0.839 
Ca 0.148 0.687 0.132 0.404 0.586 0.276 0.818 0.460 
Cl 0.301 0.499 0.850 0.146 0.192 0.683 0.917 0.894 
K 0.375 0.001 0.141 0.010 0.441 0.003 0.287 0.489 
Na 0.281 0.492 0.927 0.645 0.193 0.672 0.391 0.228 
P 0.484 0.431 0.411 0.244 0.222 0.936 0.476 0.659 
Male Urine SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
uVol 0.501 0.328 0.556 0.141 0.148 0.714 0.101 0.240 
uVolW 0.239 0.049 0.652 0.558 0.274 0.794 0.088 0.175 
uLeu 0.191 0.045 0.048 0.068 0.017 0.234 0.718 0.922 
uOsmoll 0.637 0.137 0.589 0.463 0.076 0.101 0.287 0.205 
uKeton 0.019 0.184 0.249 0.065 0.011 0.982 0.957 0.838 
upH 0.421 0.017 0.036 0.001 0.087 0.866 0.200 0.191 
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Female Weights SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Weight_27 0.808 0.546 0.206 0.294 0.735 0.928 0.886 0.678 
growthRate 0.000 0.684 0.875 0.167 0.415 0.094 0.573 0.133 
FeedMean 0.419 0.883 0.242 0.633 0.619 0.647 0.391 0.425 
Female Haematology SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
WBC 0.202 0.315 0.418 0.229 0.904 0.382 0.234 0.122 
RBC 0.462 0.638 0.173 0.584 0.387 0.059 0.312 0.688 
HGB 0.382 0.420 0.271 0.916 0.769 0.369 0.049 0.037 
HCT 0.174 0.603 0.091 0.330 0.642 0.948 0.089 0.342 
MCV 0.427 0.914 0.300 0.547 0.369 0.695 0.631 0.608 
MCH 0.770 0.881 0.420 0.088 0.480 0.653 0.580 0.459 
MCHC 0.974 0.348 0.690 0.765 0.929 0.502 0.022 0.096 
PLT 0.763 0.109 0.321 0.046 0.115 0.152 0.124 0.364 
LYMR 0.006 0.339 0.010 0.966 0.729 0.385 0.301 0.591 
LYMA 0.057 0.497 0.962 0.382 0.408 0.326 0.323 0.444 
Female diffWBC SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
Lymphocytes 0.493 0.902 0.851 0.869 0.371 0.336 0.878 0.913 
Neutrophils 0.657 0.258 0.734 0.794 0.476 0.430 0.911 0.948 
Monocytes 0.103 0.353 0.438 0.000 0.048 0.123 0.238 0.076 
Eosinophils 0.717 0.039 0.015 0.224 0.408 0.019 0.022 0.059 
Female ClinChem SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
ALP 0.699 0.196 0.357 0.336 0.936 0.010 0.282 0.390 
ALT 0.586 0.319 0.648 0.568 0.690 0.145 0.771 0.730 
AST 0.258 1.000 0.598 0.583 0.042 0.271 0.414 0.672 
BIL 0.680 0.713 0.269 0.777 0.881 0.019 0.014 0.013 
ALB 0.299 0.427 0.553 0.500 0.785 0.260 0.545 0.374 
TP 0.015 0.223 0.825 0.786 0.105 0.736 0.522 0.411 
Glu 0.525 0.399 0.366 0.066 0.982 0.487 0.759 0.908 
CHOL 0.986 0.301 0.639 0.179 0.561 0.874 0.911 0.877 
TAG 0.695 0.385 0.423 0.608 0.071 0.291 0.215 0.252 
Crea 0.453 0.592 0.074 0.032 0.992 0.584 0.019 0.026 
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Urea 0.729 0.292 0.254 0.168 0.901 0.671 0.865 0.835 
cHGB 0.246 0.467 0.005 0.011 0.173 0.000 0.292 0.788 
Ca 0.114 0.690 0.588 0.101 0.247 0.251 0.179 0.336 
Cl 0.767 0.738 0.093 0.429 0.786 0.880 0.810 0.719 
K 0.598 0.790 0.018 0.571 0.192 0.111 0.568 0.972 
Na 0.911 0.176 0.066 0.921 0.483 0.453 0.969 0.981 
P 0.272 0.522 0.730 0.139 0.112 0.564 0.281 0.419 
Female Urine SW Control SW NK11- SW NK33- SW NK11+ SW NK33+ SW residual Bartlett Levene 
uVol 0.638 0.776 0.645 0.384 0.479 0.220 0.421 0.447 
uVolW 0.779 0.332 0.559 0.754 0.542 0.081 0.694 0.795 
uLeu 0.000 0.087 0.074 0.025 0.036 0.649 0.186 0.048 
uOsmoll 0.679 0.656 0.247 0.552 0.249 0.661 0.633 0.516 
uKeton 0.000 0.001 0.009 0.000 0.000 0.456 0.366 0.659 
upH 0.002 0.074 0.017 0.176 0.012 0.046 0.077 0.190 
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Appendix 11. Statistical analysis of data including outliers 
For male animals there are outlying values for MCV (2×), ALT (1×) and BIL (1×), while for females 
there are outlying values for Lymphocytes (1×), Neutrophils (1×), MCV (1×) and BIL (2×); see Table 6 
for a list of outliers. The results of the equivalence tests, using the historical GRACE data, are given 
below; the black lines are for the analysis including outliers while the blue lines are for the analysis 
without outliers as in Figure 5 - Figure 8. 
 
 
 
 
Results  of the classical analysis without and with outliers are given in the tables below. Note that the 
top parts of the tables are identical to the values in Table 12 and Table 13. 
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Without Outliers Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
MCV 53.96 1.4 54.27 2.7  54.61 2.7  54.03 2.1  54.46 1.8  
ALT 0.679 12.7 0.695 23.4  0.703 21.8  0.675 17.8  0.691 14.5  
BIL 7.325 17.5 7.543 19.8  8.338 25.8 t 7.985 20.2  7.830 16.4 w 
With Outliers Control NK11- NK33- NK11+ NK33+ 
Males Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
MCV 54.22 2.6 54.27 2.7  54.61 2.7  54.03 2.1  54.46 1.8  
ALT 0.679 12.7 0.695 23.4  0.703 21.8  0.721 29.8  0.691 14.5  
BIL 7.325 17.5 8.242 44.2  8.338 25.8 t 7.985 20.2  7.830 16.4 w 
 
Without Outliers Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
MCV 57.68 1.7 57.64 1.6  57.39 2.0  57.41 1.4  57.19 1.7  
Lymphocytes 67.67 6.3 67.46 6.4  67.40 5.8  67.45 5.2  69.30 6.5  
Neutrophils 28.97 14.7 29.54 13.8  29.61 14.0  29.26 12.9  27.91 15.5  
BIL 8.365 14.4 8.342 9.3  8.755 23.0  8.242 18.2  8.355 15.7  
With Outliers Control NK11- NK33- NK11+ NK33+ 
Females Mean CV Mean CV Sig Mean CV Sig Mean CV Sig Mean CV Sig 
MCV 57.68 1.7 57.64 1.6  57.58 2.7  57.41 1.4  57.19 1.7  
Lymphocytes 67.67 6.3 66.43 10.1  67.40 5.8  67.45 5.2  69.30 6.5  
Neutrophils 28.97 14.7 30.50 20.2  29.61 14.0  29.26 12.9  27.91 15.5  
BIL 8.365 14.4 8.342 9.3  9.722 45.1  9.292 46.5  8.355 15.7  
 
Conclusion: for MCV in males and Lymphocytes in females equivalence cannot be established when outliers are included in the analysis. For the classical 
analysis inclusion of outliers basically makes no difference.  
